<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biomed Res Int</journal-id><journal-id journal-id-type="iso-abbrev">Biomed Res Int</journal-id><journal-id journal-id-type="publisher-id">BMRI</journal-id><journal-title-group><journal-title>BioMed Research International</journal-title></journal-title-group><issn pub-type="ppub">2314-6133</issn><issn pub-type="epub">2314-6141</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25254207</article-id><article-id pub-id-type="pmc">4165631</article-id><article-id pub-id-type="doi">10.1155/2014/490512</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Study</subject></subj-group></article-categories><title-group><article-title>Thai Massage, and Thai Herbal Compress versus Oral Ibuprofen in Symptomatic Treatment of Osteoarthritis of the Knee: A Randomized Controlled Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1407-1358</contrib-id><name><surname>Chiranthanut</surname><given-names>Natthakarn</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3739-4723</contrib-id><name><surname>Hanprasertpong</surname><given-names>Nutthiya</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-1329-379X</contrib-id><name><surname>Teekachunhatean</surname><given-names>Supanimit</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand</aff><aff id="I2"><sup>2</sup>Center of Thai Traditional and Complementary Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand</aff><author-notes><corresp id="cor1">*Supanimit Teekachunhatean: <email>supanimit.t@cmu.ac.th</email></corresp><fn fn-type="other"><p>Academic Editor: Emanuele Marzetti</p></fn></author-notes><pub-date pub-type="ppub"><year>2014</year></pub-date><pub-date pub-type="epub"><day>1</day><month>9</month><year>2014</year></pub-date><volume>2014</volume><elocation-id>490512</elocation-id><history><date date-type="received"><day>6</day><month>6</month><year>2014</year></date><date date-type="rev-recd"><day>28</day><month>7</month><year>2014</year></date><date date-type="accepted"><day>11</day><month>8</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Natthakarn Chiranthanut et al.</copyright-statement><copyright-year>2014</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>The aim of this study was to verify the clinical responses to Thai massage (TM) and Thai herbal compression (THC) for treating osteoarthritis (OA) of the knee in comparison to oral ibuprofen. This study was a randomized, evaluator-blind, controlled trial. Sixty patients with OA of the knee were randomly assigned to receive either a one-hour session of TM or THC (three times weekly) or oral ibuprofen (three times daily). The duration of treatment was three weeks. The clinical assessments included visual analog scale assessing pain and stiffness, Lequesne's functional index, time for climbing up ten steps, and physician's and patient's overall opinions on improvement. In a within-group comparison, each treatment modality caused a significant improvement of all variables determined for outcome assessments. In an among group comparison, all modalities provided nearly comparable clinical efficacy after a three-week symptomatic treatment of OA of the knee, in which a trend toward greatest improvement was likely to be found in THC group. In conclusion, TM and THC generally provided comparable clinical efficacy to oral ibuprofen after three weeks of treatment and could be considered as complementary and alternative treatments for OA of the knee.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Osteoarthritis (OA) is considered to be the most common form of arthritis that results in structural and functional failure of synovial joints [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>]. The current paradigm holds that OA is a disease of the entire joint, involving not only the degradation of articular cartilage but also a variable subchondral bone reaction, and alteration of other joint structures, including the synovial membrane, meniscus, capsule, ligaments, and periarticular muscle [<xref rid="B3" ref-type="bibr">3</xref>]. The clinical features of OA include joint pain with activity, transient stiffness in the morning or after rest, restricted motion, joint crepitus, periarticular tenderness, bony swelling, and functional disability [<xref rid="B3" ref-type="bibr">3</xref>].</p><p>The knee is regarded as one of the most common joints frequently affected by OA [<xref rid="B4" ref-type="bibr">4</xref>]. The purposes of symptomatic treatment of OA of the knee are to control joint pain and to improve joint function [<xref rid="B3" ref-type="bibr">3</xref>]. The well-known pharmacological approach for symptomatic treatment includes oral administration of paracetamol, NSAIDs, opioids, and intra-articular corticosteroid injections [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>]. Although paracetamol should be prescribed as the preferred oral analgesic [<xref rid="B5" ref-type="bibr">5</xref>], it has been reported that the majority of patients with OA would prefer NSAIDs to paracetamol [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>]. However, NSAIDs should be used with caution in patients with peptic ulcer disease, renal insufficiency, or cardiovascular risk [<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>]. Additionally, whereas opioids can be used for pain relief when NSAIDs have failed, their advantageous effects are outweighed by increased risk of adverse events and therefore should not be prescribed routinely [<xref rid="B10" ref-type="bibr">10</xref>]. Intra-articular corticosteroid injections should be considered in patients who do not respond satisfactorily to the aforementioned treatments as well as in patients with acute exacerbations of pain and signs of local inflammation [<xref rid="B11" ref-type="bibr">11</xref>]. In addition to these limitations of conventional pharmacological management, a number of patients with OA continue to experience inadequate pain control despite being treated accordingly [<xref rid="B12" ref-type="bibr">12</xref>]. These disadvantages lead many patients to seek for alternative health care options which are more or equally effective but less toxic than the conventional treatment.</p><p>Thai traditional massage is a Thai style procedure practiced on the human body using deep compressing, rhythmic pressing, and stretching. Thai traditional massage is purposed to relax muscle and tendon, increase body flexibility, improve range of joint motion, and improve regional blood circulation. Therefore, it offers a potentially beneficial role of relieving pain and improving functionality for many painful syndromes such as myofascial back pain [<xref rid="B13" ref-type="bibr">13</xref>], chronic low back pain [<xref rid="B14" ref-type="bibr">14</xref>], and muscle tension in patients with scapulocostal syndrome [<xref rid="B15" ref-type="bibr">15</xref>].</p><p>In addition to Thai traditional massage, Thai herbal compress is another traditional treatment and rehabilitation for painful syndromes. To conduct Thai herbal compress, various kinds of herbal ingredients with analgesic, anti-inflammatory, and muscle relaxant properties are mixed and tightly wrapped in a square piece of cloth to produce an herbal compress ball and then steamed in a stacked steamer pot. An application of warm compress ball to certain parts of the body enables active herbal ingredients (including aromatic oils) to permeate through the skin, leading to the therapeutic effects similar to those of Thai traditional massage mentioned above. Thai herbal compress is to be proven effective in musculoskeletal disorders including knee pain [<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>].</p><p>Although both Thai traditional massage and Thai herbal compress are growing in popularity among Thai general public, the evidence-based data supporting their potential role for treating OA of the knee has been still limited and warrants further intensive investigation; this study aimed to explore the clinical responses and safety of both modalities in short-term symptomatic treatment of OA of the knee in comparison to oral ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID).</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Study Design</title><p>This study was a prospective, randomized, evaluator-blind, controlled study. The study was approved by the Human Research Ethics Committee of the Faculty of Medicine, Chiang Mai University, and complied with the Helsinki Declaration.</p></sec><sec id="sec2.2"><title>2.2. Subjects</title><p>The sample size calculation was based on the assumptions that mean change from baseline in VAS assessing total pain at the end of treatment was the main efficacy criterion, and the mean difference between a test treatment (<italic>&#x003bc;</italic>
<sub>2</sub>) and ibuprofen (<italic>&#x003bc;</italic>
<sub>1</sub>) was assumed to be 0 (i.e., <italic>&#x003bc;</italic>
<sub>2</sub>&#x02009;&#x02009;(test) &#x02212; <italic>&#x003bc;</italic>
<sub>1</sub>&#x02009;&#x02009;(control) = 0). The noninferiority margin (<italic>&#x003b4;</italic>) was chosen to be 60 points and the standard deviation (<italic>&#x003c3;</italic>) was estimated to be 70. By using the following formula for noninferiority trial [<xref rid="B18" ref-type="bibr">18</xref>], the required sample size to achieve an 80% power (<italic>&#x003b2;</italic> = 0.2) at <italic>&#x003b1;</italic> = 0.05 for detecting such difference was 17 patients. With a projected dropout rate of 20%, twenty patients per treatment group were needed. Consider
<disp-formula id="eq1"><label>(1)</label><mml:math id="M1"><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mrow><mml:mn mathvariant="normal">2</mml:mn></mml:mrow><mml:mo>&#x02061;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mn mathvariant="normal">2</mml:mn></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mi>&#x003c3;</mml:mi></mml:mrow><mml:mrow><mml:mn mathvariant="normal">2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003bc;</mml:mi></mml:mrow><mml:mrow><mml:mn mathvariant="normal">2</mml:mn><mml:mi>&#x02009;&#x02009;</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:mi>&#x02009;&#x02009;</mml:mi><mml:msub><mml:mrow><mml:mi>&#x003bc;</mml:mi></mml:mrow><mml:mrow><mml:mn mathvariant="normal">1</mml:mn></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:mi>&#x003b4;</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mn mathvariant="normal">2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>
</p><p>Sixty out-patients of either sex were recruited. They were aged over 45 years and had been diagnosed with unilateral or bilateral OA of the knee according to the criteria of the American College of Rheumatology [<xref rid="B19" ref-type="bibr">19</xref>] for more than three months. After discontinuation of all OA treatment modalities over the run-in period of one week (week 0), the visual analog scale (VAS) assessing total pain had to be in the range of 175&#x02013;375 out of 500. Participants had to be capable of walking. Signed informed consent was obtained prior to entry. Exclusion criteria included an underlying inflammatory arthropathy, gout, pseudogout, recent knee injury on the side affected by OA, expectation of knee arthroplasty in the near future, intra-articular corticosteroid injections within the previous three months, intolerance to NSAIDs, abnormal liver or kidney function tests, history of gastroduodenal ulcer and upper gastrointestinal hemorrhage, diabetes mellitus, poorly controlled hypertension, heart failure, pregnancy, nursing mother, and malignant tumors.</p></sec><sec id="sec2.3"><title>2.3. Treatment Procedures</title><p>The study was conducted over a period of three weeks. Patients who met the eligible criteria were randomized by a computer-generated list into three treatment groups: Thai massage, Thai herbal compress, and ibuprofen group (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The allocation sequence was carried out through placing the allocation cards in opaque, sealed, and stapled envelopes to preserve concealment. The envelopes were numbered in advance and opened sequentially when the patients met entry criteria and underwent randomization. During the entire study period, any other concurrent treatment modalities (including rescue analgesics) for the treatment of arthralgia and arthritis were not allowed.</p><sec id="sec2.3.1"><title>2.3.1. Thai Massage (TM)</title><p>The Thai massage technique selected in this study was &#x0201c;Suandok massage,&#x0201d; which is a low-risk and therapeutic-directed technique. Suandok massage has been recently developed by the research team at Faculty of Medicine, Chiang Mai University (also known locally as Suandok Hospital) in order to provide the Thai graceful massage procedures with minimized potential risks. In Suandok massage, some aggressive and potential harmful postures are thus excluded from fundamental procedures of Thai traditional massage such as compression using practitioner's knees or feet, trampling on the receiver's body, as well as fast and heavy twisting of the patient's body. Additionally, pressing onto specific Chinese acupressure points indicated for treatment of OA of the knee is also integrated in order to maximize effectiveness of Thai traditional massage. The aforementioned acupressure points included lateral and medial Xiyan (points 20 and 21, <xref ref-type="fig" rid="fig4">Figure 4</xref>), Heding (point 15, <xref ref-type="fig" rid="fig4">Figure 4</xref>), Weiyang (point 13, <xref ref-type="fig" rid="fig4">Figure 4</xref>), Weizhong (point 9, <xref ref-type="fig" rid="fig4">Figure 4</xref>), and Heyang (point 12, <xref ref-type="fig" rid="fig4">Figure 4</xref>). It is worth noting that these acupressure points frequently overlap with specific pressure points in Thai traditional massage.</p><p>Patients in TM group were assigned to receive Suandok massage on both lower extremities regardless of the affected side(s) of the knee, thirty minutes each side, three times a week on Monday, Wednesday, and Friday for three consecutive weeks. Main steps and methods of the massage are presented in <xref ref-type="table" rid="tab1">Table 1</xref>. All patients in TM group received massage from the same professional practitioner who additionally underwent a 330-hour training course of Suandok massage held by Faculty of Medicine, Chiang Mai University. The commonly used technique in Suandok massage was the manipulation in which practitioner crossed two thumbs firmly and deeply pressed along body meridians including specific acupressure points. Compression to each point lasts about ten seconds.</p></sec><sec id="sec2.3.2"><title>2.3.2. Thai Herbal Compression (THC)</title><p>Patients in THC group received application of herbal ball compress on both lower extremities. The duration, frequency, steps, and methods of THC were identical to those of TM, but the herbal ball was gently applied (simply touched without compression) along patient's meridians and upon acupressure points instead of manual manipulation as performed in Suandok massage. All patients in THC group received intervention from the same professional practitioner mentioned above.</p><p>Thai herbal compress balls were prepared by the Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University. Each herbal compress ball weighed 225&#x02009;g and contained dried herbs including<italic> Zingiber cassumunar</italic> Roxb. rhizomes (40%),<italic> Curcuma longa</italic> L. rhizomes (10%),<italic> Cymbopogon citratus</italic> (DC.) Stapf leaves and leaf sheaths (10%),<italic> Croton roxburghii</italic> N.P.Balakr. leaves (10%),<italic> Tamarindus indica</italic> L. leaves (10%),<italic> Citrus hystrix</italic> DC. peels (5%),<italic> Blumea balsamifera</italic> (L.) DC. leaves (5%),<italic> Vitex trifolia</italic> L. leaves (5%), and camphor (5%).</p><p>Before providing treatment on an individual patient, two herbal balls were steamed in a stacked steamer pot for twenty minutes. Afterwards, the first ball was wrapped with towel to protect the patient's skin from a burn due to excessive heat, and then the practitioner gently touched and rolled the herbal ball on the treated areas, approximately ten seconds for each point. Then, the towel was unwrapped when the ball was warm enough to put directly on the patient's body. The second ball was replaced when the first one was slightly lukewarm. The two herbal balls were alternately streamed and alternately used until each treatment session was achieved. After each session, the balls were wrapped in a plastic bag and kept in the freezer until reuse. This study allowed the reuse of herbal balls for three treatment visits. The new balls were replaced when the next round of treatment started.</p></sec><sec id="sec2.3.3"><title>2.3.3. Ibuprofen</title><p>One 400&#x02009;mg tablet of commercially marketed ibuprofen (Nurofen, Reckitt Benckiser Healthcare Manufacturing (Thailand) Limited) was prescribed, three times a day, immediately after meals for three weeks.</p></sec></sec><sec id="sec2.4"><title>2.4. Assessments</title><p>Clinical assessments were evaluated at the end of a run-in period (week 0) for baseline data, and then weekly following each treatment for three consecutive weeks (week 1 to week 3) (<xref ref-type="fig" rid="fig1">Figure 1</xref>). These measured variables were as follows: (1) 100&#x02009;mm VAS assessing pain over the last two days (classified into walking pain, standing pain, pain during climbing up and down stairs, night pain, resting pain, total pain, and pain during the most painful knee movement), of which 0 = no pain, 100 = severe pain; (2) 100&#x02009;mm VAS assessing stiffness over the last two days (classified into morning stiffness, stiffness after rest, and total stiffness), of which 0 = no stiffness, be able to freely move, 100 = severe stiffness, very difficult to movement; (3) 100&#x02009;mm VAS for physician's and patient's overall opinions of improvement over the last two days, of which 0 = no improvement, 100 = best possible improvement; (4) Lequesne's functional index assessing the patient's daily activities over the last two days (score ranging from 0&#x02013;24) [<xref rid="B20" ref-type="bibr">20</xref>]; (5) time for climbing up ten steps. The participants self-rated the VAS and Lequesne's functional index, and they were allowed to view their own previously recorded scores. Additionally, at the end of the study period, the patients were considered as responders if their total pain score decreased at least by 80% in comparison to the baseline value [<xref rid="B21" ref-type="bibr">21</xref>]. Clinical assessments in each patient were evaluated by the same physician who was blinded to the treatment. Nondirective interviewing for adverse events and complete physical examination were also conducted weekly for three weeks in order to assess for safety.</p></sec><sec id="sec2.5"><title>2.5. Statistical Analysis</title><p>The statistical method in the present study was performed by an intention to treat analysis. Almost all datasets of outcome variables and their changes from baseline were proved to be normally distributed according to either Kolmogorov-Smirnov or Shapiro-Wilk test. In a within-group analysis, the mean values of VAS, Lequesne's functional index, and time for climbing up ten steps between baseline and the consecutive weeks were compared by the one-way analysis of variance (ANOVA) with repeated measurement.</p><p>In an among-group comparison, the one-way ANOVA was used to determine whether the three treatment groups differed in mean values of change from a baseline in VAS assessing pain and stiffness, Lequesne's functional index, as well as time for climbing up ten steps at the end of each week. Similarly, the mean values of VAS of the physician's and patient's overall opinions on improvement among the three groups at each particular time point were compared using the same test. When any statistical significance occurred between any of the three groups, the least significant difference (LSD) test was used to demonstrate statistical significance between each of the two groups. Differences among the treatment groups in number of patients considered as responders were evaluated by chi-square or Fisher's exact test.</p></sec></sec><sec id="sec3"><title>3. Results</title><p>A total of 70 patients were enrolled into this study, of whom 10 were excluded (<xref ref-type="fig" rid="fig5">Figure 5</xref>). The remaining 60 patients were randomized into the TM, THC, and ibuprofen groups (20 patients per group). In the ibuprofen group, two patients withdrew from the study during the first week due to intolerance to the gastrointestinal adverse effects. The three treatment groups were not significantly different in baseline characteristics and baseline data for the major outcome assessment (VAS, Lequesne's functional index and time for climbing up ten steps) (<xref ref-type="table" rid="tab2">Table 2</xref>). During the entire study period, the rates of adherence to treatment in the TM and THC group were 100%, whereas the rate of compliance with medication in the ibuprofen group was 90%.</p><p>In a within-group analysis (Tables <xref ref-type="table" rid="tab3">3</xref> and <xref ref-type="table" rid="tab4">4</xref>), the mean values of every assessed parameter (i.e., VAS assessing pain and stiffness, Lequesne's functional index, and time for climbing up ten steps) in all groups were significantly improved compared with their own baselines. Notably, the improvement of all parameters reached statistical significance from the end of week 1, except for VAS assessing resting pain in TM group of which the significance was found since the end of week 2.</p><p>In an among-group analysis evaluated at the end of the study (Tables <xref ref-type="table" rid="tab5">5</xref> and <xref ref-type="table" rid="tab6">6</xref>), the mean changes from baseline in most parameters did not differ among the three groups, except for the mean changes in VAS assessing pain during climbing up and down stairs in which statistical differences were found in favor of THC compared with ibuprofen and TM. Similarly, mean changes in Lequesne's functional index also significantly differed in favor of THC compared with ibuprofen. Nevertheless, it was worth noting that statistical differences among groups at the earlier time points were rarely found.</p><p>The mean values of VAS assessing physician's overall opinion of improvement were significantly different in favor of THC compared with TM at every time point (week 1&#x02013;3), but there were no statistical significances between the remaining pairs of the three groups. On the other hand, the mean values of VAS assessing patient's overall opinion of improvement over the entire treatment period were generally comparable among the three groups, except for the end of week 1 in which THC group demonstrated significantly greater VAS than TM group (<xref ref-type="table" rid="tab7">Table 7</xref>). On the basis of the number of responders whose VAS assessing total pain decreased at least by 80% compared with the baseline, the proportion of responders at the end of the study was comparable among the three groups (the response rate was 14 out of 20 patients or 70.0% in each group).</p><p>According to the reported adverse events, gastrointestinal adverse effects (nausea or abdominal pain) were significantly found in the ibuprofen group compared with TM and THC groups (8:0:0 events). Notably, two patients experienced severe abdominal pain and needed to be withdrawn from the study during the first week after initiation of oral ibuprofen. In addition, two events of skin rash and one event of edema were also found in ibuprofen group. In the TM group, three events of muscle aches over the treated area following the first massage session were reported. The adverse symptom was self-limited within a few days. In contrast, there was no reported adverse event in THC group.</p></sec><sec id="sec4"><title>4. Discussion</title><p>The results from this prospective, randomized, evaluator-blind, controlled study revealed that Thai massage, Thai herbal compress, and oral ibuprofen caused significant improvement of all parameters determined for outcome assessments. Additionally, all modalities provided nearly comparable clinical efficacy after a three-week symptomatic treatment of OA of the knee. The outcome parameters included in this study were consistent with recommendation of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative, of which pain, function, and patient's global assessment were considered the main clinical variables to be included in OA clinical trials [<xref rid="B22" ref-type="bibr">22</xref>].</p><p>Usage of oral NSAID ibuprofen as controlled treatment in the present study was in agreement with the practice guidelines for OA recommended by the American College of Rheumatology [<xref rid="B5" ref-type="bibr">5</xref>]. An analgesic dose (1200&#x02009;mg/day) of ibuprofen was reported to be as effective as an anti-inflammatory dose (2400&#x02009;mg/day) [<xref rid="B23" ref-type="bibr">23</xref>] and also equivalent to anti-inflammatory doses of various NSAIDs such as indomethacin, phenylbutazone, and meclofenamate in relieving joint pain due to OA [<xref rid="B24" ref-type="bibr">24</xref>&#x02013;<xref rid="B26" ref-type="bibr">26</xref>]. Gastrointestinal disorders are the well-known adverse events of NSAIDs, therefore it not surprising that more patients in the ibuprofen group experienced these unwanted effects and two patients were withdrawn due to intolerance to gastrointestinal adverse effects.</p><p>Cross-sectional studies have shown that arthritis is the most frequent reason for the elderly to use complementary and alternative medicine (CAM), probably due to ineffective pain relief, or adverse effects attributed to conventional medication, or the patients' own health beliefs [<xref rid="B27" ref-type="bibr">27</xref>]. So far, increasing interest has focused on massage therapy as complementary and alternative treatment for OA [<xref rid="B28" ref-type="bibr">28</xref>]. Nonetheless, since massage characteristics such as massage technique, duration, frequency, and number of sessions are supposed to closely relate to pain relief efficacy [<xref rid="B29" ref-type="bibr">29</xref>], the massage procedure used in this study was therefore performed by the same massage practitioner and confined to a one-hour session of Suandok massage, three times weekly for three consecutive weeks, in order to standardize massage therapy given to each patient in the TM group. A three times weekly dosing protocol was likely to be adequate according to the evidence from a previous randomized dose-finding trial showing that a one-hour once weekly massage protocol is the lowest optimal dose [<xref rid="B30" ref-type="bibr">30</xref>].</p><p>Several lines of scientific evidence support the effectiveness of massage in management of pain caused by musculoskeletal disorders [<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B31" ref-type="bibr">31</xref>&#x02013;<xref rid="B35" ref-type="bibr">35</xref>] including OA of the knee [<xref rid="B36" ref-type="bibr">36</xref>&#x02013;<xref rid="B38" ref-type="bibr">38</xref>]. In the present study, a within-group analysis ascertained that TM appeared to be both statistically and clinically effective in symptomatic treatment of OA of the knee. These findings are in agreement with the previous studies demonstrating clinical efficacy of Thai massage (15-minute session, three times weekly for three weeks) [<xref rid="B36" ref-type="bibr">36</xref>], Swedish massage (one-hour session, twice weekly for four weeks, then once weekly for additional four weeks) [<xref rid="B37" ref-type="bibr">37</xref>], and self-massage (20-minute session, twice weekly during ten supervised and three unsupervised intervention sessions) [<xref rid="B38" ref-type="bibr">38</xref>] in patients with OA of the knee.</p><p>The potential underlying mechanisms of the action of massage remain unclear, but the proposed mechanisms probably include improving local blood flow; promoting venous circulation; increasing lymphatic drainage to remove waste products and reduce edema; improving the mobility of ligaments, tendons and muscle; as well as relaxing muscle tension [<xref rid="B39" ref-type="bibr">39</xref>]. Additionally, nerve transmission within large nerve fibers triggered by massage might also contribute to an analgesic effect via blocking the passage of painful stimuli entering through the spinal segment, which is known as the pain gate mechanism [<xref rid="B40" ref-type="bibr">40</xref>]. Another plausible analgesic mechanism is believed to mediate via descending inhibitory pain pathways, involving release of endogenous opioids within the spinal segment [<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>]. Besides the aforementioned possibilities, an analgesic effect of massage in animal models is also demonstrated to exert via an endogenous release of oxytocin into the plasma and in the periaqueductal grey in the midbrain [<xref rid="B43" ref-type="bibr">43</xref>&#x02013;<xref rid="B45" ref-type="bibr">45</xref>]. Oxytocin also causes an increase in beta-endorphin, L-encephalin, and dynorphin A1&#x02013;13 contents in the rat spinal cord, suggesting the involvement of endogenous opiate peptide system in oxytocin-induced analgesia [<xref rid="B46" ref-type="bibr">46</xref>]. Notably, integration of Chinese acupressure into TM might produce additive or synergistic effects in management of OA of the knee since it has been found that five minutes of acupressure stimulation on the Xiyangguan acupoint, located on the lateral side of the knee joint, causes a significant increase in regional oxygen saturation of the deeper tissues on the same side of the knee in healthy volunteers. This study revealed that TM coupled with acupressure is an attractive alternative option in treatment of OA of the knee. Additionally, TM was quite safe; it involved a low incidence of mild muscle ache which was self-limited within a few days.</p><p>Topical heat therapy (such as hot pack, heat wrap therapy, localized microwave diathermy, and THC) is shown to be effective in increasing the range of joint motion, as well as in treatment of musculoskeletal pain [<xref rid="B47" ref-type="bibr">47</xref>&#x02013;<xref rid="B51" ref-type="bibr">51</xref>]. The results reported in the present study were comparable with the previous findings demonstrating that THC, a simple and noninvasive traditional therapeutic procedure, could provide pain-reliving effects in OA of the knee [<xref rid="B51" ref-type="bibr">51</xref>].</p><p>In this study, THC was performed by gentle application without any compression of the herbal ball along meridians and upon acupressure points in order to ensure that clinical efficacy (if any) was not confounded by or attributed to pressing procedure that mimics TM. THC is proposed to exert its therapeutic effects via several possible mechanisms. First, these adventitious effects are most likely to be attributed to application of topical heat. Topical heat therapy triggers an increase in nerve conduction through small nonmyelinated C-fiber, which can inhibit pain signals entering through spinal segment [<xref rid="B52" ref-type="bibr">52</xref>]. Furthermore, an increase in temperature within skeletal muscles and soft tissue around the knees is postulated to be associated with an improvement of blood flow, leading to an elimination of inflammatory mediators from knee tissues [<xref rid="B53" ref-type="bibr">53</xref>]. Heat also improves connective tissue extensibility and range of joint motion, hence increases joint functionality [<xref rid="B54" ref-type="bibr">54</xref>]. Local application of heat is capable of improving the muscle fatigue characteristics [<xref rid="B55" ref-type="bibr">55</xref>]. In animal model, hot pack application can produce an augmented muscle force in exercised animals [<xref rid="B56" ref-type="bibr">56</xref>]. Additionally, hyperthermia results in an increased cellular level of heat shock proteins (HSPs), which are believed to mediate a protective effect against skeletal muscle damage [<xref rid="B57" ref-type="bibr">57</xref>]. Second, gentle application of herbal compress ball along the meridians and at acupressure points possibly also contributed to an analgesic effect. It was found that simple touch can produce significant improvements in immediate and sustained pain outcomes [<xref rid="B58" ref-type="bibr">58</xref>], probably via increased proprioception coupled with inhibited incoming pain signals (pain gate mechanism) [<xref rid="B40" ref-type="bibr">40</xref>]. Finally, permeation of various herbal constituents from herbal compress ball through tissues around the affected knee might play a crucial role for THC's therapeutic effects. Notably, analgesic and/or anti-inflammatory effects could be anticipated from the following constituents such as<italic> Zingiber cassumunar</italic> [<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B60" ref-type="bibr">60</xref>],<italic> Curcuma longa</italic> [<xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B62" ref-type="bibr">62</xref>],<italic> Cymbopogon citratus</italic> [<xref rid="B63" ref-type="bibr">63</xref>&#x02013;<xref rid="B65" ref-type="bibr">65</xref>],<italic> Croton roxburghii</italic> [<xref rid="B66" ref-type="bibr">66</xref>],<italic> Tamarindus indica</italic> [<xref rid="B67" ref-type="bibr">67</xref>],<italic> Citrus hystrix</italic> [<xref rid="B68" ref-type="bibr">68</xref>],<italic> Blumea balsamifera</italic> [<xref rid="B69" ref-type="bibr">69</xref>, <xref rid="B70" ref-type="bibr">70</xref>],<italic> Vitex trifolia</italic> [<xref rid="B71" ref-type="bibr">71</xref>], and camphor [<xref rid="B72" ref-type="bibr">72</xref>].</p><p>In an among-group comparison, all three modalities provided nearly comparable clinical efficacy after a three-week symptomatic treatment of OA of the knee. Nevertheless, a trend toward greatest improvement, determined by magnitude of changes in most outcome variables, was likely to be found in THC group. Furthermore there were statistically better physician's overall opinion of improvement in favor of THC compared to TM, and significantly better improvement of Lequesne's functional index in favor of THC compared to ibuprofen, whereas no adverse event was reported in THC group. These findings suggest that THC should be an attractive alternative option in symptomatic treatment of OA of the knee, in comparison to TM or oral ibuprofen. It is unclear whether combination of TM and THC, as commonly seen in real situation of traditional practices, would contribute to better clinical outcomes. This interesting issue warrants further investigation.</p><p>Some limitations regarding this study should be mentioned. The time course of clinical improvement caused by TM and THC seems to gradually accumulate over the study period and it could not ensure whether or not maximal efficacy had already been achieved at the end of week 3. Further study with a longer study period should be pursued. Additionally, there was no posttreatment follow-up to evaluate the carryover effect produced by each treatment modality, especially TM and THC. Actually, the efficacy of massage sessions on pain relief has been shown to last several more weeks despite discontinuation of treatment [<xref rid="B73" ref-type="bibr">73</xref>]. Similarly, beneficial effects of deep heating therapy via microwave diathermy (three 30-minute sessions a week for four weeks) on improvement of pain, muscle strength, and physical function in patients with moderate OA of the knee have been demonstrated to be sustained over 12 months of follow-up [<xref rid="B49" ref-type="bibr">49</xref>]. This potential carryover benefit should be further investigated. Another limitation that each assigned treatment was unable to be adequately blinded to the patients, possibly resulted in bias. Lastly, a small sample size of this study might contribute to an inadequate power to differentiate the significant difference in clinical efficacy among groups (if any). Therefore, further study using a sufficiently large sample size is warranted.</p></sec><sec id="sec5"><title>5. Conclusion</title><p>TM, THC, and oral ibuprofen caused a significant improvement of all variables determined for outcome assessments. All modalities provided nearly comparable clinical efficacy after a three-week symptomatic treatment of OA of the knee, in which a trend toward greatest improvement was likely to be found in THC group. TM and THC were generally safe and free from systemic adverse effects. Both modalities could be therefore considered as effective alternative options for treatment of OA of the knee, especially in individuals who do not wish to receive oral NSAIDs or who experienced systemic unwanted effects from oral NSAIDs.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by the Faculty of Medicine, Chiang Mai University, Thailand. The authors are grateful for the editorial assistance of Ruth Leatherman, an English language consultant under contract with the Faculty of Medicine, Chiang Mai University. The authors would also like to acknowledge Chiang Mai Provincial Public Health Office for providing Thai herbal compress balls used in this study. Acknowledgments are also extended to Ms. Sujitra Techatoei for her assistance on performing statistical analysis and secretarial work.</p></ack><sec sec-type="conflict"><title>Conflict of Interests</title><p>Natthakarn Chiranthanut and Supanimit Teekachunhatean were members of the working group that developed Suandok massage. Supanimit Teekachunhatean also involves in conducting of a nonprofit training course of Suandok massage held by Faculty of Medicine, Chiang Mai University. All authors do not have a direct financial relation with the commercial identities mentioned in the paper.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Creamer</surname><given-names>P</given-names></name><name><surname>Hochberg</surname><given-names>MC</given-names></name></person-group><article-title>Osteoarthritis</article-title><source><italic>The Lancet</italic></source><year>1997</year><volume>350</volume><issue>9076</issue><fpage>503</fpage><lpage>508</lpage><pub-id pub-id-type="other">2-s2.0-0030858911</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nuki</surname><given-names>G</given-names></name></person-group><article-title>Osteoarthritis: a problem of joint failure</article-title><source><italic>Zeitschrift fur Rheumatologie</italic></source><year>1999</year><volume>58</volume><issue>3</issue><fpage>142</fpage><lpage>147</lpage><pub-id pub-id-type="other">2-s2.0-0033015701</pub-id><pub-id pub-id-type="pmid">10441841</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>DJ</given-names></name><name><surname>Felson</surname><given-names>DT</given-names></name></person-group><article-title>Osteoarthritis</article-title><source><italic>British Medical Journal</italic></source><year>2006</year><volume>332</volume><issue>7542</issue><fpage>639</fpage><lpage>642</lpage><pub-id pub-id-type="other">2-s2.0-33645234002</pub-id><pub-id pub-id-type="pmid">16543327</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bobacz</surname><given-names>K</given-names></name></person-group><article-title>Pharmacologic treatment of hand-, knee- and hip-osteoarthritis</article-title><source><italic>Wiener Medizinische Wochenschrift</italic></source><year>2013</year><volume>163</volume><issue>9-10</issue><fpage>236</fpage><lpage>242</lpage><pub-id pub-id-type="other">2-s2.0-84879001856</pub-id><pub-id pub-id-type="pmid">23715933</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochberg</surname><given-names>MC</given-names></name><name><surname>Altman</surname><given-names>RD</given-names></name><name><surname>April</surname><given-names>KT</given-names></name><etal/></person-group><article-title>American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee</article-title><source><italic>Arthritis Care and Research</italic></source><year>2012</year><volume>64</volume><issue>4</issue><fpage>465</fpage><lpage>474</lpage><pub-id pub-id-type="other">2-s2.0-84859773681</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pincus</surname><given-names>T</given-names></name><name><surname>Koch</surname><given-names>GG</given-names></name><name><surname>Sokka</surname><given-names>T</given-names></name><etal/></person-group><article-title>A randomised, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee</article-title><source><italic>Arthritis and Rheumatism</italic></source><year>2001</year><volume>44</volume><issue>7</issue><fpage>1587</fpage><lpage>1598</lpage><pub-id pub-id-type="pmid">11465710</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pincus</surname><given-names>T</given-names></name><name><surname>Koch</surname><given-names>G</given-names></name><name><surname>Lei</surname><given-names>H</given-names></name><etal/></person-group><article-title>Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placedo controlled, crossover clinical trials in patients with knee or hip osteoarthritis</article-title><source><italic>Annals of the Rheumatic Diseases</italic></source><year>2004</year><volume>63</volume><issue>8</issue><fpage>931</fpage><lpage>939</lpage><pub-id pub-id-type="other">2-s2.0-3242736488</pub-id><pub-id pub-id-type="pmid">15082468</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Neil</surname><given-names>CK</given-names></name><name><surname>Hanlon</surname><given-names>JT</given-names></name><name><surname>Marcum</surname><given-names>ZA</given-names></name></person-group><article-title>Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics</article-title><source><italic>The American Journal of Geriatric Pharmacotherapy</italic></source><year>2012</year><volume>10</volume><issue>6</issue><fpage>331</fpage><lpage>342</lpage><pub-id pub-id-type="other">2-s2.0-84870567136</pub-id><pub-id pub-id-type="pmid">23036838</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trelle</surname><given-names>S</given-names></name><name><surname>Reichenbach</surname><given-names>S</given-names></name><name><surname>Wandel</surname><given-names>S</given-names></name><etal/></person-group><article-title>Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis</article-title><source><italic>British Medical Journal</italic></source><year>2011</year><volume>342</volume><issue>7789</issue><fpage>p. 154</fpage><pub-id pub-id-type="publisher-id">c7086</pub-id><pub-id pub-id-type="other">2-s2.0-78751695197</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>N&#x000fc;esch</surname><given-names>E</given-names></name><name><surname>Rutjes</surname><given-names>AW</given-names></name><name><surname>Husni</surname><given-names>E</given-names></name><name><surname>Welch</surname><given-names>V</given-names></name><name><surname>J&#x000fc;ni</surname><given-names>P</given-names></name></person-group><article-title>Oral or transdermal opioids for osteoarthritis of the knee or hip</article-title><source><italic>The Cochrane Database of Systematic Reviews</italic></source><year>2009</year><volume>7</volume><issue>4</issue><pub-id pub-id-type="publisher-id">CD003115</pub-id><pub-id pub-id-type="other">2-s2.0-75349083835</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellamy</surname><given-names>N</given-names></name><name><surname>Campbell</surname><given-names>J</given-names></name><name><surname>Robinson</surname><given-names>V</given-names></name><name><surname>Gee</surname><given-names>T</given-names></name><name><surname>Bourne</surname><given-names>R</given-names></name><name><surname>Wells</surname><given-names>G</given-names></name></person-group><article-title>Intraarticular corticosteroid for treatment of osteoarthritis of the knee</article-title><source><italic>The Cochrane Database of Systematic Reviews</italic></source><year>2005</year><issue>2</issue><pub-id pub-id-type="publisher-id">CD005328</pub-id><pub-id pub-id-type="other">2-s2.0-21844460832</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sofat</surname><given-names>N</given-names></name><name><surname>Ejindu</surname><given-names>V</given-names></name><name><surname>Kiely</surname><given-names>P</given-names></name></person-group><article-title>What makes osteoarthritis painful? The evidence for local and central pain processing</article-title><source><italic>Rheumatology</italic></source><year>2011</year><volume>50</volume><issue>12</issue><fpage>2157</fpage><lpage>2165</lpage><pub-id pub-id-type="other">2-s2.0-82355169073</pub-id><pub-id pub-id-type="pmid">21954151</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumnerddee</surname><given-names>W</given-names></name></person-group><article-title>Effectiveness comparison between Thai traditional massage and Chinese acupuncture for myofascial back pain in Thai military personnel: a preliminary report.</article-title><source><italic>Journal of the Medical Association of Thailand</italic></source><year>2009</year><volume>92</volume><issue>supplement 1</issue><fpage>S117</fpage><lpage>S123</lpage><pub-id pub-id-type="other">2-s2.0-79952257306</pub-id><pub-id pub-id-type="pmid">21299184</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netchanok</surname><given-names>S</given-names></name><name><surname>Wendy</surname><given-names>M</given-names></name><name><surname>Marie</surname><given-names>C</given-names></name><name><surname>Siobhan</surname><given-names>O</given-names></name></person-group><article-title>The effectiveness of Swedish massage and traditional Thai massage in treating chronic low back pain: a review of the literature</article-title><source><italic>Complementary Therapies in Clinical Practice</italic></source><year>2012</year><volume>18</volume><issue>4</issue><fpage>227</fpage><lpage>234</lpage><pub-id pub-id-type="other">2-s2.0-84867333937</pub-id><pub-id pub-id-type="pmid">23059437</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buttagat</surname><given-names>V</given-names></name><name><surname>Eungpinichpong</surname><given-names>W</given-names></name><name><surname>Chatchawan</surname><given-names>U</given-names></name><name><surname>Arayawichanon</surname><given-names>P</given-names></name></person-group><article-title>Therapeutic effects of traditional Thai massage on pain, muscle tension and anxiety in patients with scapulocostal syndrome: a randomized single-blinded pilot study</article-title><source><italic>Journal of Bodywork and Movement Therapies</italic></source><year>2012</year><volume>16</volume><issue>1</issue><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="other">2-s2.0-84155164909</pub-id><pub-id pub-id-type="pmid">22196428</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Artkarn</surname><given-names>C</given-names></name></person-group><source><italic>Effects of oral medication and oral medication combined with herb ball massage on pain in patients with musculoskeletal disorders [M.S. thesis]</italic></source><year>2006</year><publisher-loc>Chiang Mai, Bangkok</publisher-loc><publisher-name> The Graduate School, Master of Public Health, Chiang Mai university</publisher-name></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sukonthasarn</surname><given-names>P</given-names></name></person-group><article-title>The effectiveness of hot herbal compresion and knee exercise on knee joint pain reduction among the elderly</article-title><source><italic>Thai Health Promotion Journal</italic></source><year>2004</year><volume>1</volume><issue>1</issue><fpage>23</fpage><lpage>35</lpage></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>SC</given-names></name><name><surname>Shao</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name></person-group><source><italic>Sample Size Calculations in Clinical Research</italic></source><year>2003</year><publisher-loc>New York, NY, USA</publisher-loc><publisher-name>Taylor &#x00026; Francis</publisher-name></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altman</surname><given-names>R</given-names></name><name><surname>Asch</surname><given-names>E</given-names></name><name><surname>Bloch</surname><given-names>D</given-names></name><etal/></person-group><article-title>Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association</article-title><source><italic>Arthritis and Rheumatism</italic></source><year>1986</year><volume>29</volume><issue>8</issue><fpage>1039</fpage><lpage>1052</lpage><pub-id pub-id-type="other">2-s2.0-0022465236</pub-id><pub-id pub-id-type="pmid">3741515</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lequesne</surname><given-names>M</given-names></name></person-group><article-title>Indices of severity and disease activity for osteoarthritis</article-title><source><italic>Seminars in Arthritis and Rheumatism</italic></source><year>1991</year><volume>20</volume><issue>6</issue><fpage>48</fpage><lpage>54</lpage><pub-id pub-id-type="other">2-s2.0-0025828560</pub-id><pub-id pub-id-type="pmid">1866630</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pham</surname><given-names>T</given-names></name><name><surname>van der Heijde</surname><given-names>D</given-names></name><name><surname>Altman</surname><given-names>RD</given-names></name><etal/></person-group><article-title>OMERACT-OARSI initiative: osteoarthritis research society international set of responder criteria for osteoarthritis clinical trials revisited</article-title><source><italic>Osteoarthritis and Cartilage</italic></source><year>2004</year><volume>12</volume><issue>5</issue><fpage>389</fpage><lpage>399</lpage><pub-id pub-id-type="other">2-s2.0-2342652256</pub-id><pub-id pub-id-type="pmid">15094138</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dougados</surname><given-names>M</given-names></name><name><surname>LeClaire</surname><given-names>P</given-names></name><name><surname>Van der Heijde</surname><given-names>D</given-names></name><name><surname>Bloch</surname><given-names>DA</given-names></name><name><surname>Bellamy</surname><given-names>N</given-names></name><name><surname>Altman</surname><given-names>RD</given-names></name></person-group><article-title>Response criteria for clinical trials on osteoarthritis of the knee and hip: A report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative</article-title><source><italic>Osteoarthritis and Cartilage</italic></source><year>2000</year><volume>8</volume><issue>6</issue><fpage>395</fpage><lpage>403</lpage><pub-id pub-id-type="other">2-s2.0-0034528514</pub-id><pub-id pub-id-type="pmid">11069723</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname><given-names>JD</given-names></name><name><surname>Brandt</surname><given-names>KD</given-names></name><name><surname>Katz</surname><given-names>BP</given-names></name><name><surname>Kalasinski</surname><given-names>LA</given-names></name><name><surname>Ryan</surname><given-names>SI</given-names></name></person-group><article-title>Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee</article-title><source><italic>The New England Journal of Medicine</italic></source><year>1991</year><volume>325</volume><issue>2</issue><fpage>87</fpage><lpage>91</lpage><pub-id pub-id-type="other">2-s2.0-0025835964</pub-id><pub-id pub-id-type="pmid">2052056</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Bl&#x000e9;court</surname><given-names>JJ</given-names></name></person-group><article-title>A comparative study of ibuprofen (&#x0201c;Brufen&#x0201d;) and indomethacin in uncomplicated arthrosis</article-title><source><italic>Current Medical Research and Opinion</italic></source><year>1975</year><volume>3</volume><issue>8</issue><fpage>477</fpage><lpage>480</lpage><pub-id pub-id-type="other">2-s2.0-0016764413</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moxley</surname><given-names>TE</given-names></name><name><surname>Royer</surname><given-names>GL</given-names></name><name><surname>Hearron</surname><given-names>MS</given-names></name><name><surname>Donovan</surname><given-names>JF</given-names></name><name><surname>Levi</surname><given-names>L</given-names></name></person-group><article-title>Ibuprofen versus buffered phenylbutazone in the treatment of osteoarthritis: double blind trial</article-title><source><italic>Journal of the American Geriatrics Society</italic></source><year>1975</year><volume>23</volume><issue>8</issue><fpage>343</fpage><lpage>349</lpage><pub-id pub-id-type="other">2-s2.0-0016816797</pub-id><pub-id pub-id-type="pmid">1097489</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimmino</surname><given-names>MA</given-names></name><name><surname>Cutolo</surname><given-names>M</given-names></name><name><surname>Samanta</surname><given-names>E</given-names></name><name><surname>Accardo</surname><given-names>S</given-names></name></person-group><article-title>Short-term treatment of osteoarthritis: a comparison of sodium meclofenamate and ibuprofen</article-title><source><italic>The Journal of International Medical Research</italic></source><year>1982</year><volume>10</volume><issue>1</issue><fpage>46</fpage><lpage>52</lpage><pub-id pub-id-type="other">2-s2.0-0020041568</pub-id><pub-id pub-id-type="pmid">7060823</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Dube</surname><given-names>CE</given-names></name><name><surname>Eaton</surname><given-names>CB</given-names></name><name><surname>McAlindon</surname><given-names>TE</given-names></name><name><surname>Lapane</surname><given-names>KL</given-names></name></person-group><article-title>Longitudinal use of complementary and alternative medicine among older adults with radiographic knee osteoarthritis</article-title><source><italic>Clinical Therapeutics</italic></source><year>2013</year><volume>35</volume><issue>11</issue><fpage>1690</fpage><lpage>1702</lpage><pub-id pub-id-type="pmid">24145044</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shengelia</surname><given-names>R</given-names></name><name><surname>Parker</surname><given-names>SJ</given-names></name><name><surname>Ballin</surname><given-names>M</given-names></name><name><surname>George</surname><given-names>T</given-names></name><name><surname>Reid</surname><given-names>MC</given-names></name></person-group><article-title>Complementary therapies for osteoarthritis: are they effective?</article-title><source><italic>Pain Management Nursing</italic></source><year>2013</year><volume>14</volume><issue>4</issue><fpage>e274</fpage><lpage>e288</lpage><pub-id pub-id-type="other">2-s2.0-84858427854</pub-id><pub-id pub-id-type="pmid">24315281</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ezzo</surname><given-names>J</given-names></name><name><surname>Haraldsson</surname><given-names>BG</given-names></name><name><surname>Gross</surname><given-names>AR</given-names></name><etal/></person-group><article-title>Massage for mechanical neck disorders: a systematic review</article-title><source><italic>Spine</italic></source><year>2007</year><volume>32</volume><issue>3</issue><fpage>353</fpage><lpage>362</lpage><pub-id pub-id-type="other">2-s2.0-33846672109</pub-id><pub-id pub-id-type="pmid">17268268</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perlman</surname><given-names>AI</given-names></name><name><surname>Ali</surname><given-names>A</given-names></name><name><surname>Njike</surname><given-names>VY</given-names></name><etal/></person-group><article-title>Massage therapy for osteoarthritis of the knee: a randomized dose-finding trial</article-title><source><italic>PLoS ONE</italic></source><year>2012</year><volume>7</volume><issue>2</issue><pub-id pub-id-type="publisher-id">e30248</pub-id><pub-id pub-id-type="other">2-s2.0-84856718728</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frey Law</surname><given-names>LA</given-names></name><name><surname>Evans</surname><given-names>S</given-names></name><name><surname>Knudtson</surname><given-names>J</given-names></name><name><surname>Nus</surname><given-names>S</given-names></name><name><surname>Scholl</surname><given-names>K</given-names></name><name><surname>Sluka</surname><given-names>KA</given-names></name></person-group><article-title>Massage reduces pain perception and hyperalgesia in experimental muscle pain: a randomized, controlled trial</article-title><source><italic>Journal of Pain</italic></source><year>2008</year><volume>9</volume><issue>8</issue><fpage>714</fpage><lpage>721</lpage><pub-id pub-id-type="other">2-s2.0-47549106479</pub-id><pub-id pub-id-type="pmid">18455480</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherman</surname><given-names>KJ</given-names></name><name><surname>Cherkin</surname><given-names>DC</given-names></name><name><surname>Hawkes</surname><given-names>RJ</given-names></name><name><surname>Miglioretti</surname><given-names>DL</given-names></name><name><surname>Deyo</surname><given-names>RA</given-names></name></person-group><article-title>Randomized trial of therapeutic massage for chronic neck pain</article-title><source><italic>The Clinical Journal of Pain</italic></source><year>2009</year><volume>25</volume><issue>3</issue><fpage>233</fpage><lpage>238</lpage><pub-id pub-id-type="other">2-s2.0-67649236151</pub-id><pub-id pub-id-type="pmid">19333174</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez-Reif</surname><given-names>M</given-names></name><name><surname>Field</surname><given-names>T</given-names></name><name><surname>Krasnegor</surname><given-names>J</given-names></name><name><surname>Theakston</surname><given-names>H</given-names></name></person-group><article-title>Lower back pain is reduced and range of motion increased after massage therapy</article-title><source><italic>International Journal of Neuroscience</italic></source><year>2001</year><volume>106</volume><issue>3-4</issue><fpage>131</fpage><lpage>145</lpage><pub-id pub-id-type="other">2-s2.0-0035050617</pub-id><pub-id pub-id-type="pmid">11264915</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherkin</surname><given-names>DC</given-names></name><name><surname>Sherman</surname><given-names>KJ</given-names></name><name><surname>Deyo</surname><given-names>RA</given-names></name><name><surname>Shekelle</surname><given-names>PG</given-names></name></person-group><article-title>A review of the evidence for the effectiveness, safety, and cost of acupuncture, massage therapy, and spinal manipulation for back pain</article-title><source><italic>Annals of Internal Medicine</italic></source><year>2003</year><volume>138</volume><issue>11</issue><fpage>898</fpage><lpage>906</lpage><pub-id pub-id-type="other">2-s2.0-0038520920</pub-id><pub-id pub-id-type="pmid">12779300</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preyde</surname><given-names>M</given-names></name></person-group><article-title>Effectiveness of massage therapy for subacute low-back pain: a randomized controlled trial</article-title><source><italic>Canadian Medical Association Journal</italic></source><year>2000</year><volume>162</volume><issue>13</issue><fpage>1815</fpage><lpage>1820</lpage><pub-id pub-id-type="other">2-s2.0-0034720718</pub-id><pub-id pub-id-type="pmid">10906914</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klinsrisuk</surname><given-names>S</given-names></name><name><surname>Eungpinichpong</surname><given-names>W</given-names></name><name><surname>Sumanont</surname><given-names>S</given-names></name><name><surname>Chatchawan</surname><given-names>U</given-names></name></person-group><article-title>The effect of modified Thai therapeutic massage on pain reduction and knee function in individuals with primary knee osteoarthritis: a randomized control trial</article-title><source><italic>Journal of Medical Technology and Physical Therapy</italic></source><year>2007</year><volume>9</volume><issue>3</issue><fpage>248</fpage><lpage>260</lpage></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perlman</surname><given-names>AI</given-names></name><name><surname>Sabina</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name><name><surname>Njike</surname><given-names>VY</given-names></name><name><surname>Katz</surname><given-names>DL</given-names></name></person-group><article-title>Massage therapy for osteoarthritis of the knee: a randomized controlled trial</article-title><source><italic>Archives of Internal Medicine</italic></source><year>2006</year><volume>166</volume><issue>22</issue><fpage>2533</fpage><lpage>2538</lpage><pub-id pub-id-type="other">2-s2.0-33845489120</pub-id><pub-id pub-id-type="pmid">17159021</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atkins</surname><given-names>DV</given-names></name><name><surname>Eichler</surname><given-names>DA</given-names></name></person-group><article-title>The effects of self-massage on osteoarthritis of the knee: a randomized, controlled trial</article-title><source><italic>International Journal of Therapeutic Massage and Bodywork</italic></source><year>2013</year><volume>6</volume><issue>1</issue><fpage>4</fpage><lpage>14</lpage><pub-id pub-id-type="other">2-s2.0-84875401666</pub-id><pub-id pub-id-type="pmid">23482239</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goats</surname><given-names>GC</given-names></name></person-group><article-title>Massage - The scientific basis of an ancient art. Part 2. Physiological and therapeutic effects</article-title><source><italic>British Journal of Sports Medicine</italic></source><year>1994</year><volume>28</volume><issue>3</issue><fpage>153</fpage><lpage>156</lpage><pub-id pub-id-type="other">2-s2.0-0028023229</pub-id><pub-id pub-id-type="pmid">8000810</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bowsher</surname><given-names>D</given-names></name></person-group><source><italic>Modulation of Nociceptive Input</italic></source><year>1988</year><publisher-name>Heinemann Medical</publisher-name></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basbaum</surname><given-names>AI</given-names></name><name><surname>Fields</surname><given-names>HL</given-names></name></person-group><article-title>Endogenous pain control mechanisms: review and hypothesis</article-title><source><italic>Annals of Neurology</italic></source><year>1978</year><volume>4</volume><issue>5</issue><fpage>451</fpage><lpage>462</lpage><pub-id pub-id-type="other">2-s2.0-0018159356</pub-id><pub-id pub-id-type="pmid">216303</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>J</given-names></name></person-group><article-title>Pain mechanisms: a review. 3. Endogenous pain mechanisms</article-title><source><italic>Australian Journal of Physiotherapy</italic></source><year>1982</year><volume>27</volume><fpage>135</fpage><lpage>143</lpage></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lund</surname><given-names>I</given-names></name><name><surname>Ge</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Repeated massage-like stimulation induces long-term effects on nociception: contribution of oxytocinergic mechanisms</article-title><source><italic>The European Journal of Neuroscience</italic></source><year>2002</year><volume>16</volume><issue>2</issue><fpage>330</fpage><lpage>338</lpage><pub-id pub-id-type="other">2-s2.0-0036976861</pub-id><pub-id pub-id-type="pmid">12169113</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uvnas-Moberg</surname><given-names>K</given-names></name><name><surname>Bruzelius</surname><given-names>G</given-names></name><name><surname>Alster</surname><given-names>P</given-names></name><name><surname>Lundeberg</surname><given-names>T</given-names></name></person-group><article-title>The antinociceptive effect of non-noxious sensory stimulation is mediated partly through oxytocinergic mechanisms</article-title><source><italic>Acta Physiologica Scandinavica</italic></source><year>1993</year><volume>149</volume><issue>2</issue><fpage>199</fpage><lpage>204</lpage><pub-id pub-id-type="other">2-s2.0-0027455165</pub-id><pub-id pub-id-type="pmid">8266809</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>Y</given-names></name><name><surname>Lundeberg</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name></person-group><article-title>Blockade effect of mu and kappa opioid antagonists on the anti-nociception induced by intra-periaqueductal grey injection of oxytocin in rats</article-title><source><italic>Brain Research</italic></source><year>2002</year><volume>927</volume><issue>2</issue><fpage>204</fpage><lpage>207</lpage><pub-id pub-id-type="other">2-s2.0-0037081449</pub-id><pub-id pub-id-type="pmid">11821014</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name></person-group><article-title>Intrathecal administration of oxytocin induces analgesia in low back pain involving the endogenous opiate peptide system</article-title><source><italic>Spine</italic></source><year>1994</year><volume>19</volume><issue>8</issue><fpage>867</fpage><lpage>871</lpage><pub-id pub-id-type="other">2-s2.0-0028299604</pub-id><pub-id pub-id-type="pmid">8009342</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kain</surname><given-names>J</given-names></name><name><surname>Martorello</surname><given-names>L</given-names></name><name><surname>Swanson</surname><given-names>E</given-names></name><name><surname>Sego</surname><given-names>S</given-names></name></person-group><article-title>Comparison of an indirect tri-planar myofascial release (MFR) technique and a hot pack for increasing range of motion</article-title><source><italic>Journal of Bodywork and Movement Therapies</italic></source><year>2011</year><volume>15</volume><issue>1</issue><fpage>63</fpage><lpage>67</lpage><pub-id pub-id-type="other">2-s2.0-78649915768</pub-id><pub-id pub-id-type="pmid">21147420</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>JM</given-names></name><name><surname>Mooney</surname><given-names>V</given-names></name><name><surname>Matheson</surname><given-names>LN</given-names></name><etal/></person-group><article-title>Continuous low-level heat wrap therapy for the prevention and early phase treatment of delayed-onset muscle soreness of the low back: a randomized controlled trial</article-title><source><italic>Archives of Physical Medicine and Rehabilitation</italic></source><year>2006</year><volume>87</volume><issue>10</issue><fpage>1310</fpage><lpage>1317</lpage><pub-id pub-id-type="other">2-s2.0-33749153845</pub-id><pub-id pub-id-type="pmid">17023239</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabini</surname><given-names>A</given-names></name><name><surname>Piazzini</surname><given-names>DB</given-names></name><name><surname>Tancredi</surname><given-names>G</given-names></name><etal/></person-group><article-title>Deep heating therapy via microwave diathermy relieves pain and improves physical function in patients with knee osteoarthritis: a double-blind randomized clinical trial</article-title><source><italic>European Journal of Physical and Rehabilitation Medicine</italic></source><year>2012</year><volume>48</volume><issue>4</issue><fpage>549</fpage><lpage>559</lpage><pub-id pub-id-type="other">2-s2.0-84868653341</pub-id><pub-id pub-id-type="pmid">22820824</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabini</surname><given-names>A</given-names></name><name><surname>Piazzini</surname><given-names>DB</given-names></name><name><surname>Bertolini</surname><given-names>C</given-names></name><etal/></person-group><article-title>Effects of local microwave diathermy on Shoulder pain and function in patients with rotator cuff tendinopathy in comparison To subacromial corticosteroid injections: a single-blind randomized trial</article-title><source><italic>The Journal of Orthopaedic and Sports Physical Therapy</italic></source><year>2012</year><volume>42</volume><issue>4</issue><fpage>363</fpage><lpage>370</lpage><pub-id pub-id-type="other">2-s2.0-84860580895</pub-id><pub-id pub-id-type="pmid">22281781</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lekutai</surname><given-names>S</given-names></name><name><surname>Tansuwannon</surname><given-names>W</given-names></name><name><surname>Sereechotchahiran</surname><given-names>S</given-names></name><name><surname>Buakham</surname><given-names>P</given-names></name></person-group><article-title>Pain-relieving effects of hot herbal compress in patients with knee osteoarthritis</article-title><source><italic>Journal of Thai Traditional &#x00026; Alternative Medicine</italic></source><year>2008</year><volume>6</volume><fpage>219</fpage><lpage>228</lpage></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>DePace</surname><given-names>DM</given-names></name><name><surname>Newton</surname><given-names>R</given-names></name></person-group><source><italic>Anatomic and Functional Aspects of Pain-Evaluation and Management with Thermal Agents</italic></source><year>1996</year><publisher-name>F.A. Davis</publisher-name></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Symons</surname><given-names>TB</given-names></name><name><surname>Clasey</surname><given-names>JL</given-names></name><name><surname>Gater</surname><given-names>DR</given-names></name><name><surname>Yates</surname><given-names>JW</given-names></name></person-group><article-title>Effects of deep heat as a preventative mechanism on delayed onset muscle soreness</article-title><source><italic>Journal of Strength and Conditioning Research</italic></source><year>2004</year><volume>18</volume><issue>1</issue><fpage>155</fpage><lpage>161</lpage><pub-id pub-id-type="other">2-s2.0-1642385472</pub-id><pub-id pub-id-type="pmid">14971967</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>VJ</given-names></name><name><surname>Ward</surname><given-names>AR</given-names></name><name><surname>Jung</surname><given-names>P</given-names></name></person-group><article-title>The effect of heat on tissue extensibility: a comparison of deep and superficial heating</article-title><source><italic>Archives of Physical Medicine and Rehabilitation</italic></source><year>2005</year><volume>86</volume><issue>4</issue><fpage>819</fpage><lpage>825</lpage><pub-id pub-id-type="other">2-s2.0-16844371104</pub-id><pub-id pub-id-type="pmid">15827938</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadler</surname><given-names>SF</given-names></name><name><surname>Feinberg</surname><given-names>JH</given-names></name><name><surname>Reisman</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effect of topical heat on electromyographic power density spectrum in subjects with myofascial pain and normal controls: a pilot study</article-title><source><italic>American Journal of Physical Medicine &#x00026; Rehabilitation</italic></source><year>2001</year><volume>80</volume><issue>11</issue><fpage>809</fpage><lpage>815</lpage><pub-id pub-id-type="other">2-s2.0-0034778992</pub-id><pub-id pub-id-type="pmid">11805451</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaguchi</surname><given-names>A</given-names></name><name><surname>Ookawara</surname><given-names>T</given-names></name><name><surname>Shimada</surname><given-names>T</given-names></name></person-group><article-title>Inhibitory effect of a combination of thermotherapy with exercise therapy on progression of muscle atrophy</article-title><source><italic>Journal of Physical Therapy Science</italic></source><year>2010</year><volume>22</volume><issue>1</issue><fpage>17</fpage><lpage>22</lpage><pub-id pub-id-type="other">2-s2.0-77950572351</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maglara</surname><given-names>AA</given-names></name><name><surname>Vasilaki</surname><given-names>A</given-names></name><name><surname>Jackson</surname><given-names>MJ</given-names></name><name><surname>McArdle</surname><given-names>A</given-names></name></person-group><article-title>Damage to developing mouse skeletal muscle myotubes in culture: Protective effect of heat shock proteins</article-title><source><italic>Journal of Physiology</italic></source><year>2003</year><volume>548</volume><issue>3</issue><fpage>837</fpage><lpage>846</lpage><pub-id pub-id-type="other">2-s2.0-0037986478</pub-id><pub-id pub-id-type="pmid">12598587</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kutner</surname><given-names>JS</given-names></name><name><surname>Smith</surname><given-names>MC</given-names></name><name><surname>Corbin</surname><given-names>L</given-names></name><etal/></person-group><article-title>Massage therapy versus simple touch to improve pain and mood in patients with advanced cancer: a randomized trial</article-title><source><italic>Annals of Internal Medicine</italic></source><year>2008</year><volume>149</volume><issue>6</issue><fpage>369</fpage><lpage>379</lpage><pub-id pub-id-type="other">2-s2.0-51949097776</pub-id><pub-id pub-id-type="pmid">18794556</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozaki</surname><given-names>Y</given-names></name><name><surname>Kawahara</surname><given-names>N</given-names></name><name><surname>Harada</surname><given-names>M</given-names></name></person-group><article-title>Anti-inflammatory effect of <italic>Zingiber cassumunar</italic> ROXB. and its active principles</article-title><source><italic>Chemical and Pharmaceutical Bulletin</italic></source><year>1991</year><volume>39</volume><issue>9</issue><fpage>2353</fpage><lpage>2356</lpage><pub-id pub-id-type="other">2-s2.0-0025992016</pub-id><pub-id pub-id-type="pmid">1804548</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panthong</surname><given-names>A</given-names></name><name><surname>Kanjanapothi</surname><given-names>D</given-names></name><name><surname>Niwatananant</surname><given-names>W</given-names></name><name><surname>Tuntiwachwuttikul</surname><given-names>P</given-names></name><name><surname>Reutrakul</surname><given-names>V</given-names></name></person-group><article-title>Anti-inflammatory activity of compound D {(E)-4-(3',4'-dimethoxyphenyl)but-3-en-2-ol} isolated from <italic>Zingiber cassumunar</italic> Roxb</article-title><source><italic>Phytomedicine</italic></source><year>1997</year><volume>4</volume><issue>3</issue><fpage>207</fpage><lpage>212</lpage><pub-id pub-id-type="other">2-s2.0-3843099390</pub-id><pub-id pub-id-type="pmid">23195477</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chainani-Wu</surname><given-names>N</given-names></name></person-group><article-title>Safety and anti-inflammatory activity of curcumin: a component of tumeric (<italic>Curcuma longa</italic>)</article-title><source><italic>Journal of Alternative and Complementary Medicine</italic></source><year>2003</year><volume>9</volume><issue>1</issue><fpage>161</fpage><lpage>168</lpage><pub-id pub-id-type="other">2-s2.0-0037291286</pub-id><pub-id pub-id-type="pmid">12676044</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antoine</surname><given-names>F</given-names></name><name><surname>Simard</surname><given-names>JC</given-names></name><name><surname>Girard</surname><given-names>D</given-names></name></person-group><article-title>Curcumin inhibits agent-induced human neutrophil functions in vitro and lipopolysaccharide-induced neutrophilic infiltration in vivo</article-title><source><italic>International Immunopharmacology</italic></source><year>2013</year><volume>17</volume><issue>4</issue><fpage>1101</fpage><lpage>1107</lpage><pub-id pub-id-type="pmid">24157330</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carbajal</surname><given-names>D</given-names></name><name><surname>Casaco</surname><given-names>A</given-names></name><name><surname>Arruzazabala</surname><given-names>L</given-names></name><name><surname>Gonzalez</surname><given-names>R</given-names></name><name><surname>Tolon</surname><given-names>Z</given-names></name></person-group><article-title>Pharmacological study of <italic>Cymbopogon citratus</italic> leaves</article-title><source><italic>Journal of Ethnopharmacology</italic></source><year>1989</year><volume>25</volume><issue>1</issue><fpage>103</fpage><lpage>107</lpage><pub-id pub-id-type="other">2-s2.0-0024601173</pub-id><pub-id pub-id-type="pmid">2716341</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viana</surname><given-names>GSB</given-names></name><name><surname>Vale</surname><given-names>TG</given-names></name><name><surname>Pinho</surname><given-names>RSN</given-names></name><name><surname>Matos</surname><given-names>FJA</given-names></name></person-group><article-title>Antinociceptive effect of the essential oil from <italic>Cymbopogon citratus</italic> in mice</article-title><source><italic>Journal of Ethnopharmacology</italic></source><year>2000</year><volume>70</volume><issue>3</issue><fpage>323</fpage><lpage>327</lpage><pub-id pub-id-type="other">2-s2.0-0034662470</pub-id><pub-id pub-id-type="pmid">10837994</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francisco</surname><given-names>V</given-names></name><name><surname>Figueirinha</surname><given-names>A</given-names></name><name><surname>Neves</surname><given-names>BM</given-names></name><etal/></person-group><article-title>
<italic>Cymbopogon citratus</italic> as source of new and safe anti-inflammatory drugs: bio-guided assay using lipopolysaccharide-stimulated macrophages</article-title><source><italic>Journal of Ethnopharmacology</italic></source><year>2011</year><volume>133</volume><issue>2</issue><fpage>818</fpage><lpage>827</lpage><pub-id pub-id-type="other">2-s2.0-78651410773</pub-id><pub-id pub-id-type="pmid">21075192</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sivakumar</surname><given-names>T</given-names></name><name><surname>Rajavel</surname><given-names>R</given-names></name><name><surname>Karthikeyan</surname><given-names>D</given-names></name></person-group><article-title>Anti-pyretic and anti-inflammatory activity of chloroform extract of <italic>Croton roxburghii</italic> in standard animal models</article-title><source><italic>Oriental Pharmacy and Experimental Medicine</italic></source><year>2008</year><volume>8</volume><issue>3</issue><fpage>252</fpage><lpage>259</lpage></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhadoriya</surname><given-names>SS</given-names></name><name><surname>Mishra</surname><given-names>V</given-names></name><name><surname>Raut</surname><given-names>S</given-names></name><name><surname>Ganeshpurkar</surname><given-names>A</given-names></name><name><surname>Jain</surname><given-names>SK</given-names></name></person-group><article-title>Anti-inflammatory and antinociceptive activities of a hydroethanolic extract of Tamarindus indica leaves</article-title><source><italic>Scientia Pharmaceutica</italic></source><year>2012</year><volume>80</volume><issue>3</issue><fpage>685</fpage><lpage>700</lpage><pub-id pub-id-type="other">2-s2.0-84866524242</pub-id><pub-id pub-id-type="pmid">23008815</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leray</surname><given-names>V</given-names></name><name><surname>Freuchet</surname><given-names>B</given-names></name><name><surname>Le Bloc'h</surname><given-names>J</given-names></name><name><surname>Jeusette</surname><given-names>I</given-names></name><name><surname>Torre</surname><given-names>C</given-names></name><name><surname>Nguyen</surname><given-names>P</given-names></name></person-group><article-title>Effect of citrus polyphenol- and curcumin-supplemented diet on inflammatory state in obese cats</article-title><source><italic>The British Journal of Nutrition</italic></source><year>2011</year><volume>106</volume><issue>supplement 1</issue><fpage>S198</fpage><lpage>S201</lpage><pub-id pub-id-type="other">2-s2.0-84856393832</pub-id><pub-id pub-id-type="pmid">22005428</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Blumeaenes A-J, sesquiterpenoid esters from <italic>Blumea balsamifera</italic> with no inhibitory activity</article-title><source><italic>Planta Medica</italic></source><year>2010</year><volume>76</volume><issue>9</issue><fpage>897</fpage><lpage>902</lpage><pub-id pub-id-type="other">2-s2.0-77953817710</pub-id><pub-id pub-id-type="pmid">20101563</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Xie</surname><given-names>C</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Fang</surname><given-names>L</given-names></name></person-group><article-title>Isolation, characterization, and no inhibitory activities of sesquiterpenes from <italic>Blumea balsamifera</italic>
</article-title><source><italic>Journal of Agricultural and Food Chemistry</italic></source><year>2012</year><volume>60</volume><issue>32</issue><fpage>8051</fpage><lpage>8058</lpage><pub-id pub-id-type="other">2-s2.0-84865152528</pub-id><pub-id pub-id-type="pmid">22823402</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsui</surname><given-names>M</given-names></name><name><surname>Kumar-Roine</surname><given-names>S</given-names></name><name><surname>Darius</surname><given-names>HT</given-names></name><name><surname>Chinain</surname><given-names>M</given-names></name><name><surname>Laurent</surname><given-names>D</given-names></name><name><surname>Pauillac</surname><given-names>S</given-names></name></person-group><article-title>Characterisation of the anti-inflammatory potential of <italic>Vitex trifolia</italic> L. (Labiatae), a multipurpose plant of the Pacific traditional medicine</article-title><source><italic>Journal of Ethnopharmacology</italic></source><year>2009</year><volume>126</volume><issue>3</issue><fpage>427</fpage><lpage>433</lpage><pub-id pub-id-type="other">2-s2.0-70449628883</pub-id><pub-id pub-id-type="pmid">19778597</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Hyun</surname><given-names>E</given-names></name><name><surname>Yoon</surname><given-names>WJ</given-names></name><etal/></person-group><article-title>In vitro anti-inflammatory and anti-oxidative effects of <italic>Cinnamomum camphora</italic> extracts</article-title><source><italic>Journal of Ethnopharmacology</italic></source><year>2006</year><volume>103</volume><issue>2</issue><fpage>208</fpage><lpage>216</lpage><pub-id pub-id-type="other">2-s2.0-29144508550</pub-id><pub-id pub-id-type="pmid">16182479</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moyer</surname><given-names>CA</given-names></name><name><surname>Rounds</surname><given-names>J</given-names></name><name><surname>Hannum</surname><given-names>JW</given-names></name></person-group><article-title>A meta-analysis of massage therapy research</article-title><source><italic>Psychological Bulletin</italic></source><year>2004</year><volume>130</volume><issue>1</issue><fpage>3</fpage><lpage>18</lpage><pub-id pub-id-type="other">2-s2.0-0348198110</pub-id><pub-id pub-id-type="pmid">14717648</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Schedule of treatment and assessment of this study. Clinical evaluation was performed on Day 1 (D1) of each week before receiving an assigned treatment or medication.</p></caption><graphic xlink:href="BMRI2014-490512.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Meridians (L1&#x02013;L4 energy lines) on the right lower extremity in the supine position.</p></caption><graphic xlink:href="BMRI2014-490512.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Meridians and pressure points on lateral aspect of the right lower extremity and medial aspect of the left lower extremity in the left lateral recumbent position.</p></caption><graphic xlink:href="BMRI2014-490512.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Pressure points located at the right knee; (a) posterior aspect and (b) anterior aspect.</p></caption><graphic xlink:href="BMRI2014-490512.004"/></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Flow chart of patients who participated in the clinical trial.</p></caption><graphic xlink:href="BMRI2014-490512.005"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Main steps and methods of Suandok massage used in this study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">&#x02009;</th><th align="left" rowspan="1" colspan="1">Step of massage</th><th align="left" rowspan="1" colspan="1">Method</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">Massage on the right lower extremity in the supine position (<xref ref-type="fig" rid="fig2">Figure 2</xref>)</td><td align="left" rowspan="1" colspan="1">Massage practitioner kneeled at the right side of the patient, started thumb pressing at the right lower extremity along L1&#x02013;L4 meridians, respectively, and then crossed the two hands with palm down to press on groin to &#x0201c;open the wind gate&#x0201d; for thirty seconds.</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">Massage on lateral aspect of the right lower extremity and medial aspect of the left lower extremity in the left lateral recumbent position (<xref ref-type="fig" rid="fig3">Figure 3</xref>)</td><td align="left" rowspan="1" colspan="1">Massage practitioner kneeled behind the patient, started thumb pressing at the three points (point numbers 1&#x02013;3) located at right gluteal region, and continued thumb pressing at posterior aspect of the right thigh along L5 meridian and at the point number 4, respectively. Next, crossed the two hands with palm down to press at posterolateral aspect of the right lower leg along L6 meridian and finished with massage on the right foot. Afterwards, switched to massage on the left lower extremity by crossing the two hands with palm down to press at medial aspect of the left thigh along L7 meridian, then performed thumb pressing at the four points located at the left thigh and at popliteal fossa (point numbers 5&#x02013;8), and continued thumb pressing at medial aspect of the left lower leg along L8 meridian, and then finished with massage on left foot.</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Massage on the left lower extremity in the supine position</td><td align="left" rowspan="1" colspan="1">Followed step 1, but performed on the left lower extremity.</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">Massage on lateral aspect of the left lower extremity and medial aspect of the right lower extremity in the right lateral recumbent position</td><td align="left" rowspan="1" colspan="1">Followed step 2, but performed on the left lower extremity.</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">Massage on posterior aspect of both lower extremities in the prone position and massage on the posterior aspect of both knees (<xref ref-type="fig" rid="fig4">Figure 4(a)</xref>)</td><td align="left" rowspan="1" colspan="1">Massage practitioner kneeled at the right side of the patient; started massage from both feet up to upper hips along posterior aspect of both extremities and then pressed on six points located at the posterior aspect of both knees (point numbers 9&#x02013;14).</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">Massage on the anterior aspect of both knees in the supine position (<xref ref-type="fig" rid="fig4">Figure 4(b)</xref>) </td><td align="left" rowspan="1" colspan="1">Massage practitioner kneeled at the right side of the patient and pressed on eight points located above and around the patella of both knees (point numbers 15&#x02013;22).</td></tr></tbody></table></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Demographic characteristics and baseline data for the major outcome assessments of participants evaluated at the end of a run-in period (week 0).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Characteristics</th><th align="center" colspan="3" rowspan="1">Treatment groups</th><th align="center" rowspan="2" colspan="1">
<italic>P</italic> value</th></tr><tr><th align="center" rowspan="1" colspan="1">TM</th><th align="center" rowspan="1" colspan="1">THC</th><th align="center" rowspan="1" colspan="1">Ibuprofen</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic>n</italic> (male: female)</td><td align="center" rowspan="1" colspan="1">20 (6&#x02009;:&#x02009;14)</td><td align="center" rowspan="1" colspan="1">20 (5&#x02009;:&#x02009;15)</td><td align="center" rowspan="1" colspan="1">20 (5&#x02009;:&#x02009;15)</td><td align="center" rowspan="1" colspan="1">0.918</td></tr><tr><td align="left" rowspan="1" colspan="1">Age (y)<sup>&#x000a7;</sup>
</td><td align="center" rowspan="1" colspan="1">65.45 &#x000b1; 9.75</td><td align="center" rowspan="1" colspan="1">63.70 &#x000b1; 6.07</td><td align="center" rowspan="1" colspan="1">62.25 &#x000b1; 9.50</td><td align="center" rowspan="1" colspan="1">0.504</td></tr><tr><td align="left" rowspan="1" colspan="1">Body weight (kg)<sup>&#x000a7;</sup>
</td><td align="center" rowspan="1" colspan="1">65.37 &#x000b1; 19.92</td><td align="center" rowspan="1" colspan="1">65.00 &#x000b1; 12.86</td><td align="center" rowspan="1" colspan="1">62.37 &#x000b1; 10.32</td><td align="center" rowspan="1" colspan="1">0.787</td></tr><tr><td align="left" rowspan="1" colspan="1">Height (m)<sup>&#x000a7;</sup>
</td><td align="center" rowspan="1" colspan="1">1.53 &#x000b1; 0.08</td><td align="center" rowspan="1" colspan="1">1.55 &#x000b1; 0.08</td><td align="center" rowspan="1" colspan="1">1.54 &#x000b1; 0.07</td><td align="center" rowspan="1" colspan="1">0.749</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)<sup>&#x000a7;</sup>
</td><td align="center" rowspan="1" colspan="1">27.78 &#x000b1; 8.20</td><td align="center" rowspan="1" colspan="1">26.76 &#x000b1; 3.56</td><td align="center" rowspan="1" colspan="1">26.30 &#x000b1; 4.56</td><td align="center" rowspan="1" colspan="1">0.712</td></tr><tr><td align="left" rowspan="1" colspan="1">Duration of OA (y)<sup>&#x000a7;</sup>
</td><td align="center" rowspan="1" colspan="1">7.37 &#x000b1; 7.16</td><td align="center" rowspan="1" colspan="1">6.45 &#x000b1; 4.87</td><td align="center" rowspan="1" colspan="1">7.95 &#x000b1; 8.20</td><td align="center" rowspan="1" colspan="1">0.787</td></tr><tr><td align="left" rowspan="1" colspan="1">Localization of OA</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">0.893</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Right knee </td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Left knee</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Both knees</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">Kellgren and Lawrence X-ray grade (knee)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Grade 2 </td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">0.461</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Grade 3 </td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">0.832</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Grade 4</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">0.629</td></tr><tr><td align="left" rowspan="1" colspan="1">VAS assessing pain (mm)<sup>&#x000a7;</sup>
</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Walking pain</td><td align="center" rowspan="1" colspan="1">58.05 &#x000b1; 13.48</td><td align="center" rowspan="1" colspan="1">61.40 &#x000b1; 17.94</td><td align="center" rowspan="1" colspan="1">53.35 &#x000b1; 13.70</td><td align="center" rowspan="1" colspan="1">0.250</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Standing pain</td><td align="center" rowspan="1" colspan="1">55.10 &#x000b1; 13.29</td><td align="center" rowspan="1" colspan="1">54.85 &#x000b1; 19.80</td><td align="center" rowspan="1" colspan="1">52.50 &#x000b1; 18.84</td><td align="center" rowspan="1" colspan="1">0.875</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Pain during climbing up and down stairs</td><td align="center" rowspan="1" colspan="1">55.80 &#x000b1; 20.75</td><td align="center" rowspan="1" colspan="1">62.80 &#x000b1; 21.22</td><td align="center" rowspan="1" colspan="1">58.20 &#x000b1; 22.37</td><td align="center" rowspan="1" colspan="1">0.580</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Night pain</td><td align="center" rowspan="1" colspan="1">54.60 &#x000b1; 20.35</td><td align="center" rowspan="1" colspan="1">40.00 &#x000b1; 26.28</td><td align="center" rowspan="1" colspan="1">50.20 &#x000b1; 19.81</td><td align="center" rowspan="1" colspan="1">0.115</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Resting pain</td><td align="center" rowspan="1" colspan="1">35.65 &#x000b1; 18.83</td><td align="center" rowspan="1" colspan="1">41.20 &#x000b1; 21.88</td><td align="center" rowspan="1" colspan="1">39.50 &#x000b1; 18.81</td><td align="center" rowspan="1" colspan="1">0.667</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Total pain<sup>a</sup>
</td><td align="center" rowspan="1" colspan="1">259.20 &#x000b1; 56.20</td><td align="center" rowspan="1" colspan="1">260.25 &#x000b1; 68.86</td><td align="center" rowspan="1" colspan="1">253.75 &#x000b1; 63.45</td><td align="center" rowspan="1" colspan="1">0.941</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Pain during the most painful knee movement</td><td align="center" rowspan="1" colspan="1">74.60 &#x000b1; 14.34</td><td align="center" rowspan="1" colspan="1">76.70 &#x000b1; 14.94</td><td align="center" rowspan="1" colspan="1">76.95 &#x000b1; 14.07</td><td align="center" rowspan="1" colspan="1">0.853</td></tr><tr><td align="left" rowspan="1" colspan="1">VAS assessing stiffness (mm)<sup>&#x000a7;</sup>
</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Morning stiffness</td><td align="center" rowspan="1" colspan="1">59.15 &#x000b1; 22.88</td><td align="center" rowspan="1" colspan="1">51.30 &#x000b1; 30.89</td><td align="center" rowspan="1" colspan="1">54.00 &#x000b1; 23.79</td><td align="center" rowspan="1" colspan="1">0.629</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Stiffness after rest</td><td align="center" rowspan="1" colspan="1">53.80 &#x000b1; 22.16</td><td align="center" rowspan="1" colspan="1">49.80 &#x000b1; 26.86</td><td align="center" rowspan="1" colspan="1">53.10 &#x000b1; 24.17</td><td align="center" rowspan="1" colspan="1">0.859</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Total stiffness<sup>b</sup>
</td><td align="center" rowspan="1" colspan="1">112.95 &#x000b1; 41.04</td><td align="center" rowspan="1" colspan="1">101.10 &#x000b1; 55.42</td><td align="center" rowspan="1" colspan="1">107.10 &#x000b1; 44.75</td><td align="center" rowspan="1" colspan="1">0.733</td></tr><tr><td align="left" rowspan="1" colspan="1">Lequesne's functional index<sup>&#x000a7;</sup>
</td><td align="center" rowspan="1" colspan="1"> 13.50 &#x000b1; 2.38</td><td align="center" rowspan="1" colspan="1">13.25 &#x000b1; 4.07</td><td align="center" rowspan="1" colspan="1"> 12.70 &#x000b1; 2.41</td><td align="center" rowspan="1" colspan="1">0.700</td></tr><tr><td align="left" rowspan="1" colspan="1">Time for climbing up ten steps<sup>&#x000a7;</sup>
</td><td align="center" rowspan="1" colspan="1">11.80 &#x000b1; 4.26</td><td align="center" rowspan="1" colspan="1">13.55 &#x000b1; 5.61</td><td align="center" rowspan="1" colspan="1">13.15 &#x000b1; 6.57</td><td align="center" rowspan="1" colspan="1">0.584</td></tr></tbody></table><table-wrap-foot><fn><p>
<sup>&#x000a7;</sup>Data represent mean &#x000b1; SD.</p></fn><fn><p>
<sup>
a</sup>Summation of VAS that assessed walking pain, standing pain, pain during climbing up and down stairs, night pain, and resting pain.</p></fn><fn><p>
<sup>
b</sup>Summation of VAS that assessed morning stiffness and stiffness after rest.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Mean VAS assessing pain (mm) in intent-to-treat patients (<italic>n</italic> = 20/group).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">Treatment group</th><th align="center" rowspan="1" colspan="1">Week 0 </th><th align="center" rowspan="1" colspan="1">Week 1</th><th align="center" rowspan="1" colspan="1">Week 2</th><th align="center" rowspan="1" colspan="1">Week 3</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">VAS assessing pain (mm)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Walking pain</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">58.05 &#x000b1; 13.48</td><td align="center" rowspan="1" colspan="1">42.45 &#x000b1; 15.02&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">26.60 &#x000b1; 12.19&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">17.70 &#x000b1; 15.01&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">61.40 &#x000b1; 17.94</td><td align="center" rowspan="1" colspan="1">39.00 &#x000b1; 18.91&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">26.70 &#x000b1; 16.66&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">16.35 &#x000b1; 17.54&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">53.35 &#x000b1; 13.70</td><td align="center" rowspan="1" colspan="1">36.40 &#x000b1; 16.48&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">28.75 &#x000b1; 16.47&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">19.85 &#x000b1; 17.96&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Standing pain</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">55.10 &#x000b1; 13.29</td><td align="center" rowspan="1" colspan="1">38.25 &#x000b1; 20.88&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">26.90 &#x000b1; 19.15&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">20.05 &#x000b1; 21.69&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">54.85 &#x000b1; 19.80</td><td align="center" rowspan="1" colspan="1">40.75 &#x000b1; 19.19&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">26.35 &#x000b1; 17.81&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">16.70 &#x000b1; 15.69&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">52.50 &#x000b1; 18.84</td><td align="center" rowspan="1" colspan="1">35.45 &#x000b1; 16.89&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">26.85 &#x000b1; 18.63&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">19.80 &#x000b1; 17.84&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Pain during climbing up and down stairs</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">55.80 &#x000b1; 20.75</td><td align="center" rowspan="1" colspan="1">45.50 &#x000b1; 22.19&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">31.75 &#x000b1; 20.26&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">23.65 &#x000b1; 16.91&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">62.80 &#x000b1; 21.22</td><td align="center" rowspan="1" colspan="1">42.50 &#x000b1; 18.03&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">29.00 &#x000b1; 15.40&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">14.20 &#x000b1; 11.52&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">58.20 &#x000b1; 22.37</td><td align="center" rowspan="1" colspan="1">43.95 &#x000b1; 22.36&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">32.90 &#x000b1; 22.99&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">25.25 &#x000b1; 21.76&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Night pain</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">54.60 &#x000b1; 20.35</td><td align="center" rowspan="1" colspan="1">32.75 &#x000b1; 19.25&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">19.10 &#x000b1; 21.40&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">14.60 &#x000b1; 20.57&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">40.00 &#x000b1; 26.28</td><td align="center" rowspan="1" colspan="1">27.40 &#x000b1; 23.25&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">16.00 &#x000b1; 19.16&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">5.75 &#x000b1; 9.16&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">50.20 &#x000b1; 19.81</td><td align="center" rowspan="1" colspan="1">29.80 &#x000b1; 16.58&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">18.55 &#x000b1; 20.05&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">14.20 &#x000b1; 18.13&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Resting pain</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">35.65 &#x000b1; 18.83</td><td align="center" rowspan="1" colspan="1">26.80 &#x000b1; 16.59</td><td align="center" rowspan="1" colspan="1">15.20 &#x000b1; 15.26&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">11.95 &#x000b1; 14.46&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">41.20 &#x000b1; 21.88</td><td align="center" rowspan="1" colspan="1">22.45 &#x000b1; 19.87&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">11.10 &#x000b1; 14.28&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">8.55 &#x000b1; 11.07&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">39.50 &#x000b1; 18.81</td><td align="center" rowspan="1" colspan="1">24.60 &#x000b1; 17.39&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">20.05 &#x000b1; 16.12&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">9.80 &#x000b1; 13.92&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Total pain<sup>a</sup>
</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">259.20 &#x000b1; 56.20</td><td align="center" rowspan="1" colspan="1">185.75 &#x000b1; 67.31&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">119.55 &#x000b1; 71.98&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">87.95 &#x000b1; 75.81&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">260.25 &#x000b1; 68.86</td><td align="center" rowspan="1" colspan="1">172.10 &#x000b1; 73.42&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">109.15 &#x000b1; 61.56&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">61.55 &#x000b1; 49.42&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">253.75 &#x000b1; 63.45</td><td align="center" rowspan="1" colspan="1">170.20 &#x000b1; 62.85&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">107.40 &#x000b1; 82.15&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">69.20 &#x000b1; 71.02&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Pain during the most painful knee movement</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">74.60 &#x000b1; 14.34</td><td align="center" rowspan="1" colspan="1">59.05 &#x000b1; 17.89&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">45.50 &#x000b1; 24.66&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">31.15 &#x000b1; 22.30&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">76.70 &#x000b1; 14.94</td><td align="center" rowspan="1" colspan="1">48.35 &#x000b1; 25.70&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">28.60 &#x000b1; 20.24&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">22.60 &#x000b1; 19.91&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">76.95 &#x000b1; 14.07</td><td align="center" rowspan="1" colspan="1">49.90 &#x000b1; 23.72&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">36.20 &#x000b1; 24.71&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">29.55 &#x000b1; 25.60&#x02217;&#x02217;&#x02217;</td></tr></tbody></table><table-wrap-foot><fn><p>Data represent mean &#x000b1; SD. <sup>a</sup>Summation of VAS that assessed walking pain, standing pain, pain during climbing up and down stairs, night pain, and resting pain. &#x02217;<italic>P </italic>&#x0003c; 0.05, &#x02217;&#x02217;<italic>P</italic> &#x0003c; 0.01, &#x02217;&#x02217;&#x02217;<italic>P</italic> &#x0003c; 0.001 versus baseline.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Mean values of VAS assessing stiffness, Lequesne's functional index, and time for climbing up ten steps in intent-to-treat patients (<italic>n</italic> = 20/group).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">Treatment group</th><th align="center" rowspan="1" colspan="1">Week 0 </th><th align="center" rowspan="1" colspan="1">Week 1</th><th align="center" rowspan="1" colspan="1">Week 2</th><th align="center" rowspan="1" colspan="1">Week 3</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">VAS assessing stiffness (mm)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Morning stiffness</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">59.15 &#x000b1; 22.88</td><td align="center" rowspan="1" colspan="1">41.90 &#x000b1; 22.63&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">29.00 &#x000b1; 20.89&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">16.65 &#x000b1; 16.68&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">51.30 &#x000b1; 30.89</td><td align="center" rowspan="1" colspan="1">34.40 &#x000b1; 21.26&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">16.80 &#x000b1; 14.24&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">5.05 &#x000b1; 6.30&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">54.00 &#x000b1; 23.79</td><td align="center" rowspan="1" colspan="1">33.10 &#x000b1; 21.67&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">23.25 &#x000b1; 20.44&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">15.60 &#x000b1; 19.56&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Stiffness after rest</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">53.80 &#x000b1; 22.16</td><td align="center" rowspan="1" colspan="1">36.85 &#x000b1; 20.58&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">23.60 &#x000b1; 17.97&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">19.95 &#x000b1; 19.04&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">49.80 &#x000b1; 26.86</td><td align="center" rowspan="1" colspan="1">30.70 &#x000b1; 22.29&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">17.85 &#x000b1; 14.50&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">10.65 &#x000b1; 12.49&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">53.10 &#x000b1; 24.17</td><td align="center" rowspan="1" colspan="1">34.70 &#x000b1; 19.16&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">24.10 &#x000b1; 20.76&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">16.30 &#x000b1; 18.28&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Total stiffness<sup>a</sup>
</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">112.95 &#x000b1; 41.04</td><td align="center" rowspan="1" colspan="1">78.75 &#x000b1; 38.88&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">52.60 &#x000b1; 36.50&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">36.60 &#x000b1; 32.22&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">101.10 &#x000b1; 55.42</td><td align="center" rowspan="1" colspan="1">65.10 &#x000b1; 41.00&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">34.65 &#x000b1; 28.35&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">15.70 &#x000b1; 15.85&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">107.10 &#x000b1; 44.75</td><td align="center" rowspan="1" colspan="1">67.80 &#x000b1; 37.47&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">47.35 &#x000b1; 38.82&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">31.90 &#x000b1; 36.28&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="left" rowspan="3" colspan="1">Lequesne's functional index (score)</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">13.50 &#x000b1; 2.38</td><td align="center" rowspan="1" colspan="1">11.18 &#x000b1; 3.13&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">9.40 &#x000b1; 3.23&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">7.73 &#x000b1; 3.30&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">13.25 &#x000b1; 4.07</td><td align="center" rowspan="1" colspan="1">10.68 &#x000b1; 3.54&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">8.30 &#x000b1; 2.93&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">6.53 &#x000b1; 3.73&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">12.70 &#x000b1; 2.41</td><td align="center" rowspan="1" colspan="1">10.20 &#x000b1; 2.59&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">8.35 &#x000b1; 3.05&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">7.85 &#x000b1; 3.31&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="left" rowspan="3" colspan="1">Time for climbing up ten steps (second)</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">11.80 &#x000b1; 4.26</td><td align="center" rowspan="1" colspan="1">10.50 &#x000b1; 3.87&#x02217;</td><td align="center" rowspan="1" colspan="1">9.10 &#x000b1; 3.24&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">8.25 &#x000b1; 3.08&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">13.55 &#x000b1; 5.61</td><td align="center" rowspan="1" colspan="1">10.70 &#x000b1; 6.34&#x02217;</td><td align="center" rowspan="1" colspan="1">8.90 &#x000b1; 3.24&#x02217;&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">7.95 &#x000b1; 2.78&#x02217;&#x02217;&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">13.15 &#x000b1; 6.57</td><td align="center" rowspan="1" colspan="1">11.55 &#x000b1; 6.23&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">10.00 &#x000b1; 4.41&#x02217;&#x02217;</td><td align="center" rowspan="1" colspan="1">9.25 &#x000b1; 3.61&#x02217;&#x02217;&#x02217;</td></tr></tbody></table><table-wrap-foot><fn><p>Data represent mean &#x000b1; SD. <sup>a</sup>Summation of VAS that assessed morning stiffness and stiffness after rest. &#x02217;<italic>P </italic>&#x0003c; 0.05, &#x02217;&#x02217;<italic>P</italic> &#x0003c; 0.01, &#x02217;&#x02217;&#x02217;<italic>P</italic> &#x0003c; 0.001 versus baseline.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Mean changes from baseline in VAS assessing pain in intent-to-treat patients (<italic>n</italic> = 20/group).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1"> Treatment group</th><th align="center" rowspan="1" colspan="1">Week 0-1</th><th align="center" rowspan="1" colspan="1">Week 0&#x02013;2</th><th align="center" rowspan="1" colspan="1">Week 0&#x02013;3</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">VAS assessing pain (mm)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Walking pain</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">&#x02212;15.60 &#x000b1; 15.25</td><td align="center" rowspan="1" colspan="1">&#x02212;31.45 &#x000b1; 13.33</td><td align="center" rowspan="1" colspan="1">&#x02212;40.35 &#x000b1; 15.55</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">&#x02212;22.40 &#x000b1; 14.09</td><td align="center" rowspan="1" colspan="1">&#x02212;34.70 &#x000b1; 18.70</td><td align="center" rowspan="1" colspan="1">&#x02212;45.05 &#x000b1; 18.76</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">&#x02212;16.95 &#x000b1; 18.35</td><td align="center" rowspan="1" colspan="1">&#x02212;24.60 &#x000b1; 22.83</td><td align="center" rowspan="1" colspan="1">&#x02212;33.50 &#x000b1; 23.80</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Standing pain</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">&#x02212;16.85 &#x000b1; 17.28</td><td align="center" rowspan="1" colspan="1">&#x02212;28.20 &#x000b1; 14.06</td><td align="center" rowspan="1" colspan="1">&#x02212;35.05 &#x000b1; 16.32</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">&#x02212;14.10 &#x000b1; 15.21</td><td align="center" rowspan="1" colspan="1">&#x02212;28.50 &#x000b1; 21.54</td><td align="center" rowspan="1" colspan="1">&#x02212;38.15 &#x000b1; 20.25</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">&#x02212;17.05 &#x000b1; 20.01</td><td align="center" rowspan="1" colspan="1">&#x02212;25.65 &#x000b1; 23.39</td><td align="center" rowspan="1" colspan="1">&#x02212;32.70 &#x000b1; 26.35</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Pain during climbing up and down stairs</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">&#x02212;10.30 &#x000b1; 11.07</td><td align="center" rowspan="1" colspan="1">&#x02212;24.05 &#x000b1; 17.40</td><td align="center" rowspan="1" colspan="1">&#x02212;32.15 &#x000b1; 19.01</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">&#x02212;20.30 &#x000b1; 15.84<sup>&#x02020;</sup>
</td><td align="center" rowspan="1" colspan="1">&#x02212;33.80 &#x000b1; 21.20</td><td align="center" rowspan="1" colspan="1">&#x02212;48.60 &#x000b1; 19.45<sup>&#x02217;,&#x02020;</sup>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">&#x02212;14.25 &#x000b1; 17.14</td><td align="center" rowspan="1" colspan="1">&#x02212;25.30 &#x000b1; 23.59</td><td align="center" rowspan="1" colspan="1">&#x02212;32.95 &#x000b1; 26.07</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Night pain</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">&#x02212;21.85 &#x000b1; 14.80</td><td align="center" rowspan="1" colspan="1">&#x02212;35.50 &#x000b1; 24.59</td><td align="center" rowspan="1" colspan="1">&#x02212;40.00 &#x000b1; 25.16</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">&#x02212;12.60 &#x000b1; 16.48</td><td align="center" rowspan="1" colspan="1">&#x02212;24.00 &#x000b1; 21.68</td><td align="center" rowspan="1" colspan="1">&#x02212;34.25 &#x000b1; 25.32</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">&#x02212;20.40 &#x000b1; 19.73</td><td align="center" rowspan="1" colspan="1">&#x02212;31.65 &#x000b1; 23.72</td><td align="center" rowspan="1" colspan="1">&#x02212;36.00 &#x000b1; 23.40</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Resting pain</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">&#x02212;8.85 &#x000b1; 21.59</td><td align="center" rowspan="1" colspan="1">&#x02212;20.45 &#x000b1; 24.80</td><td align="center" rowspan="1" colspan="1">&#x02212;23.70 &#x000b1; 27.53</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">&#x02212;18.75 &#x000b1; 26.76</td><td align="center" rowspan="1" colspan="1">&#x02212;30.10 &#x000b1; 24.60</td><td align="center" rowspan="1" colspan="1">&#x02212;32.65 &#x000b1; 24.10</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">&#x02212;14.90 &#x000b1; 12.86</td><td align="center" rowspan="1" colspan="1">&#x02212;19.45 &#x000b1; 21.22</td><td align="center" rowspan="1" colspan="1">&#x02212;29.70 &#x000b1; 24.02</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Total pain<sup>a</sup>
</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">&#x02212;73.45 &#x000b1; 38.70</td><td align="center" rowspan="1" colspan="1">&#x02212;139.65 &#x000b1; 63.68</td><td align="center" rowspan="1" colspan="1">&#x02212;171.25 &#x000b1; 71.94</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">&#x02212;88.15 &#x000b1; 54.65</td><td align="center" rowspan="1" colspan="1">&#x02212;151.10 &#x000b1; 70.92</td><td align="center" rowspan="1" colspan="1">&#x02212;198.70 &#x000b1; 71.19</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">&#x02212;83.55 &#x000b1; 64.06</td><td align="center" rowspan="1" colspan="1">&#x02212;146.35 &#x000b1; 94.02</td><td align="center" rowspan="1" colspan="1">&#x02212;184.55 &#x000b1; 92.36</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Pain during the most painful knee movement</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">&#x02212;15.55 &#x000b1; 19.69</td><td align="center" rowspan="1" colspan="1">&#x02212;29.10 &#x000b1; 25.14</td><td align="center" rowspan="1" colspan="1">&#x02212;43.45 &#x000b1; 23.00</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">&#x02212;28.35 &#x000b1; 19.00</td><td align="center" rowspan="1" colspan="1">&#x02212;48.10 &#x000b1; 18.52<sup>&#x02020;</sup>
</td><td align="center" rowspan="1" colspan="1">&#x02212;54.10 &#x000b1; 17.94</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">&#x02212;27.05 &#x000b1; 21.85</td><td align="center" rowspan="1" colspan="1">&#x02212;40.75 &#x000b1; 23.97</td><td align="center" rowspan="1" colspan="1">&#x02212;47.40 &#x000b1; 26.85</td></tr></tbody></table><table-wrap-foot><fn><p>Data represent mean &#x000b1; SD. <sup>a</sup>Summation of VAS that assessed walking pain, standing pain, pain during climbing up and down stairs, night pain, and resting pain. &#x02217;Statistical significance versus ibuprofen (<italic>P </italic>= 0.027). <sup>&#x02020;</sup>Statistical significance versus TM (<italic>P </italic>= 0.038 and <italic>P </italic>= 0.020; pain during climbing up and down stairs at week 0-1 and 0&#x02013;3, respectively, <italic>P </italic>= 0.011; pain during the most painful knee movement at week 0&#x02013;2).</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab6" orientation="portrait" position="float"><label>Table 6</label><caption><p>Mean changes from baseline in VAS assessing stiffness, Lequesne's functional index, and time for climbing up ten steps in intent-to-treat patients (<italic>n</italic> = 20/group).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">Treatment group</th><th align="center" rowspan="1" colspan="1">Week 0-1</th><th align="center" rowspan="1" colspan="1">Week 0&#x02013;2</th><th align="center" rowspan="1" colspan="1">Week 0&#x02013;3</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">VAS assessing stiffness (mm)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Morning stiffness</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">&#x02212;17.25 &#x000b1; 17.99</td><td align="center" rowspan="1" colspan="1">&#x02212;30.15 &#x000b1; 21.86</td><td align="center" rowspan="1" colspan="1">&#x02212;42.50 &#x000b1; 21.97</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">&#x02212;16.90 &#x000b1; 21.84</td><td align="center" rowspan="1" colspan="1">&#x02212;34.50 &#x000b1; 28.86</td><td align="center" rowspan="1" colspan="1">&#x02212;46.25 &#x000b1; 29.68</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">&#x02212;20.90 &#x000b1; 23.68</td><td align="center" rowspan="1" colspan="1">&#x02212;30.75 &#x000b1; 29.94</td><td align="center" rowspan="1" colspan="1">&#x02212;38.40 &#x000b1; 31.44</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Stiffness after rest</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">&#x02212;16.95 &#x000b1; 16.37</td><td align="center" rowspan="1" colspan="1">&#x02212;30.20 &#x000b1; 19.40</td><td align="center" rowspan="1" colspan="1">&#x02212;33.85 &#x000b1; 25.12</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">&#x02212;19.10 &#x000b1; 19.81</td><td align="center" rowspan="1" colspan="1">&#x02212;31.95 &#x000b1; 23.53</td><td align="center" rowspan="1" colspan="1">&#x02212;39.15 &#x000b1; 23.78</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">&#x02212;18.40 &#x000b1; 23.25</td><td align="center" rowspan="1" colspan="1">&#x02212;29.00 &#x000b1; 30.25</td><td align="center" rowspan="1" colspan="1">&#x02212;36.80 &#x000b1; 29.47</td></tr><tr><td align="left" rowspan="3" colspan="1">&#x02003;Total stiffness<sup>a</sup>
</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">&#x02212;34.20 &#x000b1; 29.54</td><td align="center" rowspan="1" colspan="1">&#x02212;60.35 &#x000b1; 38.37</td><td align="center" rowspan="1" colspan="1">&#x02212;76.35 &#x000b1; 41.56</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">&#x02212;36.00 &#x000b1; 36.45</td><td align="center" rowspan="1" colspan="1">&#x02212;66.45 &#x000b1; 48.24</td><td align="center" rowspan="1" colspan="1">&#x02212;85.40 &#x000b1; 49.46</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">&#x02212;39.30 &#x000b1; 44.51</td><td align="center" rowspan="1" colspan="1">&#x02212;59.75 &#x000b1; 59.42</td><td align="center" rowspan="1" colspan="1">&#x02212;75.20 &#x000b1; 59.45</td></tr><tr><td align="left" rowspan="3" colspan="1">Lequesne's functional index (score)</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">&#x02212;2.33 &#x000b1; 2.30</td><td align="center" rowspan="1" colspan="1">&#x02212;4.10 &#x000b1; 3.01</td><td align="center" rowspan="1" colspan="1">&#x02212;5.78 &#x000b1; 2.41</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">&#x02212;2.58 &#x000b1; 2.82</td><td align="center" rowspan="1" colspan="1">&#x02212;4.95 &#x000b1; 3.45</td><td align="center" rowspan="1" colspan="1">&#x02212;6.73 &#x000b1; 3.45&#x02217;</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">&#x02212;2.50 &#x000b1; 2.33</td><td align="center" rowspan="1" colspan="1">&#x02212;4.35 &#x000b1; 2.47</td><td align="center" rowspan="1" colspan="1">&#x02212;4.85 &#x000b1; 2.84</td></tr><tr><td align="left" rowspan="3" colspan="1">Time for climbing up ten steps (second)</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">&#x02212;1.30 &#x000b1; 2.52</td><td align="center" rowspan="1" colspan="1">&#x02212;2.70 &#x000b1; 3.15</td><td align="center" rowspan="1" colspan="1">&#x02212;3.55 &#x000b1; 3.33</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">&#x02212;2.85 &#x000b1; 4.64</td><td align="center" rowspan="1" colspan="1">&#x02212;4.65 &#x000b1; 4.08</td><td align="center" rowspan="1" colspan="1">&#x02212;5.60 &#x000b1; 4.57</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">&#x02212;1.60 &#x000b1; 1.93</td><td align="center" rowspan="1" colspan="1">&#x02212;3.15 &#x000b1; 3.42</td><td align="center" rowspan="1" colspan="1">&#x02212;3.90 &#x000b1; 4.00</td></tr></tbody></table><table-wrap-foot><fn><p>Data represent mean &#x000b1; SD. <sup>a</sup>Summation of VAS that assessed morning stiffness and stiffness after rest.</p></fn><fn><p>
&#x02217;Statistical significance versus ibuprofen (<italic>P </italic>= 0.048).</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab7" orientation="portrait" position="float"><label>Table 7</label><caption><p>100-mm VAS assessing physician's and patient's overall opinions of improvement evaluated during treatment.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">Treatment group</th><th align="center" rowspan="1" colspan="1">
<italic>n</italic>
</th><th align="center" rowspan="1" colspan="1">Week 1</th><th align="center" rowspan="1" colspan="1">Week 2</th><th align="center" rowspan="1" colspan="1">Week 3</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">Patient's overall opinion (mm)<sup>&#x000a7;</sup>
</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">38.55 &#x000b1; 20.46</td><td align="center" rowspan="1" colspan="1">60.00 &#x000b1; 19.72</td><td align="center" rowspan="1" colspan="1">77.60 &#x000b1; 16.01</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">57.10 &#x000b1; 17.70<sup>&#x02020;</sup>
</td><td align="center" rowspan="1" colspan="1">72.15 &#x000b1; 17.82</td><td align="center" rowspan="1" colspan="1">85.65 &#x000b1; 11.77</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">18<sup><italic>&#x003c0;</italic></sup>
</td><td align="center" rowspan="1" colspan="1">51.70 &#x000b1; 26.59</td><td align="center" rowspan="1" colspan="1">65.11 &#x000b1; 25.07</td><td align="center" rowspan="1" colspan="1">78.11 &#x000b1; 23.73</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="3" colspan="1">Physician's overall opinion (mm)<sup>&#x000a7;</sup>
</td><td align="center" rowspan="1" colspan="1">TM</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">26.35 &#x000b1; 9.89</td><td align="center" rowspan="1" colspan="1">36.90 &#x000b1; 10.80</td><td align="center" rowspan="1" colspan="1">51.75 &#x000b1; 10.83</td></tr><tr><td align="center" rowspan="1" colspan="1">THC</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">42.75 &#x000b1; 17.64<sup>&#x02020;&#x02020;</sup>
</td><td align="center" rowspan="1" colspan="1">56.70 &#x000b1; 15.89<sup>&#x02020;&#x02020;</sup>
</td><td align="center" rowspan="1" colspan="1">66.05 &#x000b1; 13.15<sup>&#x02020;&#x02020;</sup>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">18<sup><italic>&#x003c0;</italic></sup>
</td><td align="center" rowspan="1" colspan="1">33.90 &#x000b1; 20.05</td><td align="center" rowspan="1" colspan="1">46.50 &#x000b1; 24.68</td><td align="center" rowspan="1" colspan="1">55.28 &#x000b1; 24.20</td></tr></tbody></table><table-wrap-foot><fn><p>Data represent mean &#x000b1; SD.</p></fn><fn><p>
<sup>&#x000a7;</sup>0 = no improvement, 100 = best possible improvement.</p></fn><fn><p>
<sup><italic>&#x003c0;</italic></sup>2 patients in the ibuprofen group could not be assessed due to being withdrawn during week 1.</p></fn><fn><p>
<sup>&#x02020;</sup>Statistical significance versus TM (<italic>P </italic>= 0.010).</p></fn><fn><p>
<sup>&#x02020;&#x02020;</sup>Statistical significance versus TM (<italic>P </italic>= 0.003 at week 1, <italic>P </italic>= 0.001 at week 2, and <italic>P </italic>= 0.009 at week 3).</p></fn></table-wrap-foot></table-wrap></floats-group></article>